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Abstract 
 
Axons of the adult mammalian central nervous system (CNS) are unable to regenerate 
following axonal injury. Thus, spinal cord injury (SCI) leads to devastating and permanent 
functional impairments, the extent of which depends on the position of the lesion. At present, 
our understanding of the response to axonal injury and what underlies the failure of CNS 
axons to regenerate is far from complete. Therefore, despite various strategies proposed and 
tried, a robust method to improve axon regeneration after SCI is yet to be found. Due to 
growing evidence highlighting the role of post-transcriptional control towards protein 
expression and the importance of localised protein synthesis in axon physiology, we decided 
to investigate the post-transcriptional regulation mechanisms that could govern the 
regeneration of CNS neurons.   
At a very early time window following SCI, axon regrowth still occurs, but is however 
limited in duration and extent. This however offers a rare opportunity of learning how nature 
initiates a regenerative response in the CNS. In order to study the difference between the total 
level of RNA and the subset that is actually translated, we profiled and compared total and 
polysome-bound RNAs from spinal cords early after injury and naïve ones, and revealed 
substantial uncoupling between mRNA abundance and ribosome loading. mRNAs of genes 
related to nervous system development were highly reduced following injury, while still 
being stably loaded onto ribosomes. By analysing motifs recognised by RNA-binding 
proteins, it was discovered that mRNAs harbouring the cytoplasmic polyadenylation element 
(CPE) exhibit increased transcript abundance upon SCI relative to those that do not, and were 
highly enriched in nervous system development genes in both mouse and Drosophila 
genomes. By manipulating the expression of Cpeb1, the binding protein of CPE, we found 
that Cpeb1 is a positive regulator of regeneration in both mouse and Drosophila CNS 
neurons.  In an attempt to identify the targets of Cpeb1 mediated injury response, we 
analysed the transcriptome of naïve and injured processes from wild-type and Cpeb1 
knockout cortical neurons with RNAseq. It was found that Cpeb1 knockout processes have a 
much attenuated transcriptional activation-response towards injury. In particular, the Jun and 
Fos family of transcription factors, which are highly up-regulated upon injury in wild-type 
processes, failed to do so in their Cpeb1 knockout counterparts. In addition, Cpeb1 knockout 
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was found to have an effect on alternative polyadenylation. However, the precise molecular 
mechanisms underlying observed changes remain a subject of future studies.  
In conclusion, this study demonstrates widespread uncoupling between mRNA abundance 
and ribosome-loading in the injury response of CNS neurons, and identifies Cpeb1 as a 
conserved positive regulator of regeneration, as well as a mediator of this uncoupling effect.  
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Zusammenfassung 
 
Axone im zentralen Nervensystem (ZNS) sind nach einer Verletzung nicht in der Lage zu 
regenerieren. Daher führt eine Rückenmarksverletzung zu einer schwerwiegenden und 
dauerhaften Beeinträchtigung, dessen Umfang von der Position der Schädigung abhängig ist. 
Unser Verständnis der Reaktion nach axonaler Verletzung und der assoziierten fehlenden 
Regeneration ist gegenwärtig unzureichend. Daher gibt es trotz zahlreicher Versuche immer 
noch keine verlässliche Methode um die axonale Regeneration nach Rückenmarksverletzung 
zu fördern. Unlängst wurde die hohe Bedeutung von posttranskriptioneller Regulation für 
Proteinexpression und die Rolle von lokalisierter Proteinsynthese für die Physiologie von 
Axonen hervorgehoben. Daher haben wir entschieden posttranskriptionelle Mechanismen, 
welche zur Regeneration von ZNS-Axonen beitragen könnten, zu studieren.  
In einem kurzen Zeitfenster nach Verletzung wachsen Axone nach. Hier bietet sich die 
Möglichkeit diese in Zeit und Umfang begrenzte Regeneration zu studieren. Um die Level an 
gesamter messenger RNA (mRNA) und die Teilmenge welche tatsächlich in Proteine 
umgesetzt wird zu ermitteln, haben wir totale mRNA und polysom-gebundene mRNA in 
gesundem Rückenmark und kurze Zeit nach Verletzung analysiert. Dieser Vergleich ergab 
eine wesentliche Entkopplung zwischen gesamter mRNA-Menge und ribosomaler Beladung. 
mRNA von Genen welche mit der Entwicklung des ZNS assoziiert sind wurden nach 
Verletzung deutlich herunterreguliert, jedoch weiterhin stabil auf Ribosome geladen. Analyse 
von Motiven welche von RNA-bindenden Proteinen erkannt werden hat gezeigt dass mRNAs 
welche ein cytoplasmic polyadenylation element (CPE) aufweisen eine höhere Menge an 
Transkripten nach Verletzung aufweisen als mRNAs ohne CPE. Diese mRNAs sind zudem 
mit Genen angereichert welche sowohl in der Maus als auch in Drosophila mit der 
Entwicklung des ZNS assoziiert sind. Wir fanden durch Manipulation der Expression von 
Cpeb1, dem Bindeprotein von CPE, dass Cpeb1 ein positiver Regulator der Regeneration von 
Maus- und Drosophila-Neuronen des ZNS ist. Um die Zielgene von Cpeb1-mediierter 
Verletzungsreaktion zu identifizieren haben wir das Transkriptom von verletzten und 
unverletzten Prozessen von kortikalen Neuronen sowohl von Wildtyp-Mäusen als auch 
Cpeb1-Knockout-Mäusen per RNAseq untersucht. Die Ergebnisse haben gezeigt dass 
Prozesse mit Cpeb1-Knockout nach Verletzung eine abgemilderte Reaktion der 
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Transkriptionsaktivierung aufweisen. Besonders Gene der Jun- und Fos-Familie von 
Transkriptionsfaktoren, welche in Wildtyp-Prozessen nach Verletzung hochreguliert werden, 
zeigen eine fehlende Reaktion nach Cpeb1-Knockout. Zusätzlich wurde gezeigt dass Cpeb1-
Knockout einen Effekt auf alternative Polyadenylierung hat. Die molekularen Mechanismen 
dahinter sind Gegenstand zukünftiger Studien.  
Zusammengefasst zeigt diese Studie eine weit verbreitete Entkopplung zwischen gesamter 
mRNA-Menge und Ribosom-Beladung in der Verletzungsreaktion von ZNS-Neuronen und 
identifiziert Cpeb1 als einen konservierten positiven Regulator der Regeneration und 
Vermittler des Entkopplungseffekts.  
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1. Introduction 
1.1 Structure of a neuron 
 
The neuron is the cell type within the nervous system that relays nerve signals. There are a 
number of different types of neurons, which differ in their morphology and function, but they 
all consist of a cell soma, axons, and dendrites. Axons and dendrites are collectively called 
processes. 
The cell soma houses the nucleus and contains the majority of the organelles of the cell such 
as mitochondria, endoplasmic reticulum and Golgi apparatus. Most proteins of the neuron are 
synthesised within the cell soma. Most neurons contain one axon, which is a long process that 
can extend for great distances and connect to targets far away from the cell soma. Axons 
conduct nerve signals in the form of action potentials from the cell body towards the axon 
terminus. They are wrapped in a myelin shealth, which is an extended plasma membrane 
originating from oligodendrocytes or Schwann cells that enhances the speed of propagation 
of the action potential (Morell and Quarles, 1999). Axons connect to their targets via 
synapses. The axon terminal of the pre-synaptic cell releases neurotransmitters, which crosses 
the synaptic cleft and activate the post-synaptic cell (Lodish et al., 2000). Dendrites, in 
contrast to axons, transmit nerve signals towards the cell soma and are typically shorter. Most 
neurons contain multiple dendrites which allow them to receive signals from more than one 
neuron. Microtubules within axons and dendrites act as tracks for transport, for exchanging 
materials such as proteins, RNAs and organelles with the cell soma. This is termed 
anterograde and retrograde transport, depending on the direction of movement of the cargo 
molecules (Bramham and Wells, 2007; Setou et al., 2004). 
The nervous system is divided into two major parts, the central nervous system (CNS) and 
the peripheral nervous system (PNS). The CNS consists of the brain, spinal cord, retina and 
optic nerves. One of the distinguishing factors between the two nervous system is that 
processes of the CNS has a very limited ability to regenerate following injury, in contrast to 
PNS (Huebner and Strittmatter, 2009). 
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1.2 Spinal Cord Injury 
 
The spinal cord is a part of the CNS. It is responsible for relaying nerve signals between the 
brain and various organs of the body, as a conduit for sensory signals towards the brain and 
for motor signals originating from the brain. It also houses the neural circuits for certain 
reflexes. In a cross section, the spinal cord consists of white matter in the periphery, which 
mostly contains myelinated axons, and grey matter in the centre, which consists mainly of 
cell somas. Spinal nerves connect to the spinal cord along its length and relay signal between 
the spinal cord and the various organs connected.  
Spinal cord injury (SCI) results in disruption of communication between the brain and the 
organs whose neural circuit enters the spinal cord below the lesion site. As a result, urinary, 
musculoskeletal, gastrointestinal and respiratory functions could be affected, depending on 
the site and extent of the injury. The spinal cord, being a part of the CNS, is largely unable to 
regenerate, often resulting in permanent disabilities for SCI patients (Silva et al., 2014). As of 
2014 in the USA, acute spinal cord injury is affecting 276,000 persons, with approximately 
12,500 new cases per year. The most common neurological outcome of the injury is 
incomplete tetraplegia (45%) (National Spinal Cord Injury Statistical Centre, 2014). Less 
than 1% of spinal cord injury patients experience complete neurological recovery, with most 
patients having to rely on long-term assistance in their daily lives for matters such as mobility 
and personal care, causing dramatic impact on patients’ life and career. The long-term 
disability also leads to psychological problems such as depression and anxiety, and generates 
very high medical costs.  
Damage to the spinal cord can be categorised into two types. The first is the acute mechanical 
injury which causes shearing of axons, haemorrhage and ischemia, and is restricted locally to 
the site of injury. The other type is secondary injury that follows days to weeks after the 
initial injury, in which a milieu of processes such as inflammation, disruption of the blood-
spinal cord barrier, toxicity from free-radical and electrolyte disturbances cause further cell 
death among neurons and glia cells (Dumont et al.; Zhang et al., 2012). As Cajal y Ramon 
has observed almost a century ago, severed axons in the spinal cord do attempt to regrow, 
however the process is soon aborted (Cajal, 1928; Cajal et al., 1991; Kerschensteiner et al., 
2005). Both cell intrinsic and extrinsic factors contribute to this failure to regrow. In spite of 
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decades of research, at present there still lacks a method to robustly induce axon regrowth 
following SCI. 
 
1.3 Axonal regeneration in the CNS 
 
Axotomy induces responses in different parts of the affected neuron. The distal part of the 
axon separated from the rest of the cell by axotomy undergoes gradual degeneration, called 
Wallerian degeneration, while the proximal part of the axon reseals the ruptured membrane. 
To regrow, a growth cone has to be developed from the damaged axon end.  For axons of the 
adult mammalian CNS, which have a very limited regenerative capacity, the cut axon end 
often fails to transform into a growth cone, but develops into a retraction bulb instead (Hill et 
al., 2001; Li and Raisman, 1995). In SCI, damaged corticospinal tract (CST) axons make an 
initial attempt to regrow, but this regenerative phase is transient and abortive. During this 
phase, the axons form retraction bulbs and die back away from the lesion point (Bernstein 
and Stelzner, 1983; Cajal, 1928; Kerschensteiner et al., 2005; Li et al., 1997). 
Axotomy also induces considerable changes to the cell soma. The acute response after injury 
includes displacement of the nucleus to cell periphery, swelling of cell soma, and loss or 
retraction of synaptic terminals, processes similar across CNS and PNS neurons (Liu et al., 
2011). In the long-term, however, their responses show substantial differences. Cell somas of 
PNS neurons show signs of increased protein synthesis and metabolism. On the other hand, 
CNS neurons are atrophic and have reduced cell volume (Lieberman, 1971). Both neuron 
intrinsic and extrinsic factors have been discovered to influence the capability of axonal 
regeneration.  
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Figure 1: Response towards axonal injury in the CNS. Following injury, synaptic connection is lost, the axon 
end forms a retraction bulb and dies back. Astrocytes and microglia infiltrates the lesion zone as part of the 
inflammatory response. Axon sprouting occurs in certain cases, but is abortive, due to lack of a long-lasting 
intrinsic regenerative programme, an external environment hostile to axon growth from the inflammation, or a 
physical barrier from the glial scar.  Sometimes aberrant sprouting occurs when the axon connects with an 
inappropriate target. In other cases, injured neurons could undergo cell death. Adapted from (Horner and Gage, 
2000) 
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1.4 Factors influencing CNS axon regeneration 
 
1.4.1 Inhibitory environment 
 
Many studies have demonstrated that myelin in the CNS, but not in the PNS, contains 
inhibitory molecules to axonal regrowth. Several such inhibitors have been identified, 
including Nogo-A, myelin-associated glycoprotein (MAG), and the 
glycosylphosphatidylinositol-linkied oligodendrocyte myelin glycoprotein (OMgp) 
(Mingorance et al., 2004). These inhibitors share little structural similarities between each 
other, but they have all been found to have high binding affinity to Nogo receptor (NgR). 
NgR is part of a receptor complex that contains p75
NTR
 and Lingo-1, which triggers a 
signalling cascade involving the activation of RhoA (Mi et al., 2004; Wang et al., 2002). 
Activation of RhoA changes the dynamics of actin and microtubules, leading to growth cone 
collapse and inhibition of neurite growth (Wu et al., 2005).  
Molecules that inhibit various steps within this signalling cascade, for example C3 transferase 
and Cethrin, which inhibit Rho GTPase; and ATI-355, a humanised anti-Nogo antibody, have 
yielded encouraging results in enhancing axon regrowth and functional recovery, and some of 
these molecules have entered clinical trials (Muramatsu and Yamashita, 2014). However, 
inconsistent results have arisen from studies using a triple knockout of the three myelin 
inhibitors Nogo-A, MAG and OMgp, in which no enhanced regeneration was observed. This 
indicates that the source molecules of myelin inhibition remains unclear (Muramatsu and 
Yamashita, 2014). 
In another approach, in which a permissive growth environment is provided for the severed 
CNS axons, for example by inserting grafts from a segment of peripheral nerve, have shown 
certain promises, allowing the CNS axons to extend for long distances and to guide the 
direction of regrowth (David and Aguayo, 1981). This demonstrates the importance of a 
permissive environment, with the effect possibly contributed by cytokines, inhibitory 
molecules, growth cues etc.  However, the regenerative capacity conferred by a permissive 
graft only reaches so far as the graft itself, with the regeneration halting when the axon 
reaches the CNS environment (Côté et al., 2011). This limits the potential therapeutic use of 
the grafts, but illustrates the role played by extracellular environments.  
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1.4.2 Cell intrinsic factors 
 
On the other hand, axon regeneration capability also depends on neuron intrinsic factors. One 
of the strongest evidence that exemplifies this comes from the effect of a conditioning lesion 
on dorsal root ganglion (DRG) sensory neurons. DRG neurons have a cell soma that resides 
in the PNS, but have a bifurcating axon that has two branches, one projecting into the PNS 
and the other into the CNS. As expected, the peripheral branch is able to regenerate, whereas 
the central branch cannot. However, if the peripheral branch is subjected to injury prior to the 
central branch, the central branch gains the ability to regenerate. This is not observed if the 
conditioning lesion is done on the central branch (Neumann and Woolf, 1999; Richardson 
and Verge, 1986). This suggests that injury to the PNS axon activates a regenerative 
programme in the neuron that is able to drive regeneration in the CNS axon. 
 
1.4.2.1 Regenerative signalling pathways and gene expression programmes  
 
For some types of CNS neurons, it was demonstrated that there is a significant decline in 
ability for axon growth as they mature. For example, axons of embryonic retinal ganglion 
cells (RGCs), which is part of the CNS, extend about ten times faster than mature ones 
(Goldberg et al., 2002). Several molecules have been implicated to be the effectors behind 
this phenomenon, for example Bcl-2 and Kruppel-like factors (KLFs). Growth failure in optic 
nerves coincides with a developmentally correlated loss of Bcl-2 expression (Cho et al., 
2005).  KLFs are a set of zinc-finger transcription factors. KLF6 and KLF7, which are 
promoters of axon regrowth, are down-regulated in adult RGCs (Veldman et al., 2007). 
Conversely, KLF4, which is a strong inhibitor of axonal growth, is up-regulated in adult 
RGCs (Moore et al., 2009). These observations give rise to the hypothesis that as CNS 
neurons mature, their regenerative capability is shut off, and perhaps it could be reactivated. 
A few negative regulators of signalling pathways for growth have been discovered, the most 
prominent of which are Pten and Socs3.  
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Deletion of Pten was found to have a positive effect in regeneration, by preventing apoptosis 
and promoting axon extension in RGCs and CST neurons, as well as increasing 
compensatory sprouting from spared axons in the CST (Liu et al., 2010; Park et al., 2008). 
Pten is an antagonist of PI3K/Akt signalling, and thus a negative regulator of mammalian 
target of rapamycin (mTOR). Rapamycin treatment, which interrupts mTOR signalling, 
abolishes the regenerative effects of Pten deletion, indicating that Pten inhibits regeneration 
by suppressing mTOR (Park et al., 2008). mTOR is a regulator of cap-dependent translation, 
by controlling the activity of ribosomal S6 kinase and eukaryotic initiation factor 4E binding 
proteins (4E-BPs) (Guertin and Sabatini, 2007). The role of mTOR in regeneration is further 
implicated from the fact that mTOR levels decrease with development in RGCs and cortical 
neurons (Liu et al., 2010; Park et al., 2008). However, deletion of Tsc1, another inhibitor of 
mTOR, confers of a regenerative effect as deletion of Pten, indicating that the pro-
regenerative effects of Pten deletion do not only come from mTOR (Park et al., 2008).  
Socs3 is a negative feedback regulator of Jak/Stat signalling, being induced by this pathway 
while simultaneously suppressing it (Baker et al., 2009; Wunderlich et al., 2013). Expression 
of Socs3 is induced following injury in zebrafish optic nerves (Elsaeidi et al., 2014), and its 
deletion induces significant regeneration in mouse RGCs (Smith et al., 2009).  Confirming 
the role of Jak/Stat signalling in promoting regeneration, activation of Stat3 is increased in 
regenerating axons in Socs3 deleted RGCs and optic nerves (Sun et al., 2011). In addition, 
expression of Stat3 was found to strongly increase sprouting from lesioned CST fibres, as 
well as collateral sprouting from unlesioned fibres, with improved functional recovery 
(Bareyre et al., 2011; Lang et al., 2013). Perhaps attributing to the negative feedback loop 
relationship with Socs3, expression of Stat3 only improves initiation of axonal regrowth 
(Bareyre et al., 2011). Co-deletion of both Pten and Socs3 produces a synergistic effect in 
promoting robust and sustained axon regeneration in RGCs (Sun et al., 2011). These findings 
point out the prominent role of upstream master negative regulators in restricting regeneration 
of adult CNS axons, and demonstrates the feasibility to coax regeneration by targeting these 
inhibitors. 
Epigenetic regulation has also been implicated in controlling regeneration.  Upon axon injury 
in DRG neurons, a calcium wave originating from the injury site propagates backwards 
towards the cell soma, leading to nuclear export of the histone deacetylase 5 (Hdac5) via 
PKCµ activation. This results in increased histone H3 acetylation and up-regulation of 
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several regeneration associated genes such as c-Jun, c-Fos and Gadd45a, and subsequent 
enhanced regeneration (Cho et al., 2013). Interestingly, this was not observed in RGCs, 
suggesting this is yet another process that differentiates the regeneration capability of PNS 
and CNS neurons.  
 
1.4.2.2 Cytoskeleton organisation 
 
Regrowth of axons requires formation of a growth cone at the axon tip, and this is dependent 
on the dynamics of the microtubules and actin filaments. Upon rupture of the cell membrane 
from an injury, intra-axonal calcium is increased by diffusion. This leads to depolymerisation 
of microtubule and actin. Eventually the ruptured membrane is resealed by membrane 
collapse, and calcium removal mechanisms lower the intra-axonal calcium concentration, 
allowing repolymerisation of microtubule and actin. The actin filaments assemble at the 
leading edge of the lamellipodia to provide the mechanical force for the extension of the 
growth cone (Bradke et al., 2012; Hur et al., 2012). Stabilisation of microtubules, for example 
with taxol, a drug that stabilises the microtubule assembly, leads to formation of a growth 
cone at the site of axon lesion. On the other hand, disruption of microtubules with the drug 
nocodazole leads to formation of a retraction bulb (Ertürk et al., 2007). Part of this process 
has been shown to be regulated via Hdac5. Upon axon injury-induced nuclear export, Hdac5 
is transported to axon tips, where it deacetylates tubulin and promotes growth cone dynamics 
and axon regeneration (Cho and Cavalli, 2012).  
 
1.5 Post-transcriptional regulation of gene expression 
 
Traditionally, and until today, RNA abundance is commonly used to infer the protein levels 
of a gene. However, numerous post-transcriptional mechanisms exist that control the fate of 
an RNA, and it has recently been suggested that uncoupling of transcription and translation is 
a widespread phenomenon (Schwanhäusser et al., 2011). 
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The numerous post-transcriptional control steps for RNA fate require mechanisms to direct 
RNAs to the specific processes needed. This role is often fulfilled by sequence specific 
motifs present on RNAs, in combination with their respective binding proteins. Many of such 
motifs are present in the untranslated region (UTR) of mRNAs, particularly the 3’UTR, 
which is also generally longer than the 5’ UTR. For example, the average 3’UTR in the 
human transcriptome is more than 500nt long, in contrast to the 5’UTR, which is 150nt long 
(Mazumder et al., 2003; Pesole, 2002). So far a number of such motifs have been discovered 
situated in the 5’ and 3’ UTRs, exerting a variety of different functions, including subcellular 
localisation (Jansen, 2001), stability (Beelman and Parker, 1995) and translation efficiency 
(Sonenberg, 1994). The different levels of post-transcriptional regulation during the lifespan 
of an mRNA are introduced in the following sections. 
 
1.5.1 Subcellular localisation of RNAs 
 
Asymmetric subcellular RNA distribution is used by many cell systems to achieve polarity, 
and this is no exception in neurons. Different composition of the RNA pool in axons 
determines the availability for localised translation, and this is subject to changes in different 
contexts. For example, the repertoire of axonal mRNAs changes dynamically during 
development, indicating the different requirements for localised translation as neurons 
mature. Embryonic axons were found to have an mRNA pool enriched in cytoskeleton and 
axonal growth related genes, whereas  adult axons are enriched in genes with a role in 
inflammation (Gumy et al., 2011). The mRNA for a number of transmembrane receptors, 
such as EphB4, were found in both growth cones and cell somas of mature RGC neurons, but 
only found in cell somas in young neurons, demonstrating developmentally controlled 
trafficking of RNA (Zivraj et al., 2010). 
In an injury context, the repertoire of axonal mRNAs was also found to be different. mRNAs 
related to intracellular transport, mitochondrial function and cytoskeleton show a decrease in 
regenerating growth cones from injured cortical neurons, whereas mRNAs related to axonal 
targeting, synaptic functions show an increase (Taylor et al., 2009). Even within axons, the 
repertoire of mRNAs was found to have differences between axon shafts and growth cones. 
Although most of the growth cone transcripts are also present in axon shafts, a subset was 
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significantly enriched in growth cones, with functions related to cytoskeleton and protein 
synthesis (Zivraj et al., 2010). 
 
1.5.2 Intracellular RNA trafficking 
 
The presence of specialised mRNA pools in the axon shows that there are mechanisms which 
select and shuttle specific mRNAs to the axons (Gumy et al., 2013). In addition, the fact that 
only a few thousand transcripts from the entire mouse genome were found in axons and that 
the RNA pool differs between growth cones and axon shafts points out that the localisation of 
these mRNAs cannot be mere diffusion (Gumy et al., 2011; Zivraj et al., 2010). 
mRNAs are transported via association with trans-acting factors in messenger 
ribonucleoprotein (mRNP) complexes. RNA-binding proteins (RBPs) in these complexes 
serve as adapters between motor proteins of microtubules and the mRNA to be transported. 
This role has been confirmed for Fmrp, a known component of RNA granules, which was 
found to bind the motor protein Kif3C. Neurons expressing a dominant-negative mutant of 
Kif3c has impaired transport of Fmrp containing RNA granules (Davidovic et al., 2007). Live 
imaging of mRNPs shows that movements of mRNPs along microtubules are bidirectional 
(Amrute-Nayak and Bullock, 2012; Zhang et al., 2001). Studies in Drosophila embryos 
revealed that a localisation signal on the mRNAs regulate the number of transport proteins 
recruited to the mRNP, through which a bias in the direction of movement is created in order 
for the mRNA to reach its destination. Mutant mRNAs lacking the localisation signal still 
associate with dynein and are transported, but exhibit a much attenuated bias of movement 
when compared to wild-type ones (Amrute-Nayak and Bullock, 2012; Bullock et al., 2006). 
Studies in mouse neurons and Drosophila embryos have also shown that mRNPs transport 
mRNAs in low copy numbers, often even in single copies (Amrute-Nayak and Bullock, 2012; 
Mikl et al., 2011). Carrying a single mRNA might not be energetically efficient, but does 
allow a high spatial and temporal control of gene expression.  
Recognition of mRNAs to be packaged into mRNPs for transport is dependent on cis-
elements on the mRNA. To date the best described element is a 54 nucleotide long sequence 
in its 3’UTR called the zip-code. The zip-code targets β-actin mRNA to the axons (Willis et 
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al., 2011). The zipcode-binding protein 1 (Zbp1) binds to the zip-code and transports the 
mRNA to the axon while suppressing translation during the transport process, by preventing 
the joining of 60S subunit to the translation pre-initiation complex (Hüttelmaier et al., 2005). 
Availability of Zbp1 was found to be a limiting factor in mRNA axonal localisation and a 
critical part of axonal regeneration, when introduction of β-actin 3’UTR competes with 
endogenous actin and Gap43 mRNA in binding to Zbp1, resulting in a reduction of axonal 
regrowth (Donnelly et al., 2011). The competition between β-actin and Gap-43 mRNAs for 
Zbp1 and shuttling towards axons was found to drive different modes of axonal growth. 
Increasing axonal synthesis of β-actin at the expense of Gap-43 leads to short and highly 
branched axons. In contrast, increasing axonal synthesis of Gap-43 at the expense of β-actin 
results in long axons with few branches (Donnelly et al., 2013). 
 
Figure 2: Schematic model showing mRNA localisation determined by the relative ratios of motor proteins with 
opposing actions. A higher ratio for kinesin leads to anterograde transport into axon tips, whereas a higher ratio 
for dynein leads to retrograde transport to the cell soma. Adapted from (Gumy et al., 2013). 
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1.5.3 RNA degradation: Regulation of mRNA turnover and quality control 
 
An important part of RNA biology is its degradation, which serves the purpose of quality 
control, as well as complimenting other mechanisms to control gene expression by 
determining the lifespan of the mRNA available for translation. Control of mRNA quality 
occurs mainly via nonsense-mediated decay (NMD). After pre-mRNAs underwent splicing, 
the splicing mechanism deposits a protein complex called the exon junction complex (EJC) at 
the spliced site, which serves as a memory of the splicing event. After the mRNA is exported 
to the cytoplasm, distribution of EJCs would serve as an indication of mRNA quality and the 
basis for triggering NMD. One prevailing model is that EJCs are ejected by the ribosome as 
translation occurs. When a premature stop codon is created by faulty transcription or splicing, 
there could be EJCs still attached to the mRNA after the first round of translation, as the 
ribosome is released before it could reach the last EJCs. In this case NMD would be triggered 
and the mRNA would be targeted for degradation (Chang et al., 2007; Lejeune et al., 2003). 
Besides quality control, RNAs have different lifespans, with the half lives of RNAs differing 
in several orders of magnitude. This allows fine temporal and spatial control of gene 
expression (Peltz et al., 1991). Together with transcription, the two processes determine the 
actual amount of mRNA available to ribosomes for translation. In systems where rapid 
changes of protein expression are needed, this is especially important as changes in 
transcription will take time to take effect. For example, hypoxia induced stress increases the 
stability of lactate dehydrogenase A (Ldh-A) mRNA, allowing more efficient energy 
production in anaerobic conditions from glycolysis (Short, 2000). 
Over the last decades, many cis- and trans- factors have been discovered that influence the 
stability of given mRNA species. Of the most prominent ones are the AU-rich elements 
(AREs), a family of motifs with similar sequences located in the 3’UTR of mRNAs, 
regulating many mRNAs with fast turnover such as c-Fos, c-Myc and GM-CSF. So far the 
definition of an ARE is not concrete, but basically they all contain the pentamer AUUUA 
(Barreau et al., 2005). Initially thought to instil instability in the host RNA, AREs are now 
also known to promote stability. The heterogeneity of its action could be attributed to the 
diversity of sequences that constitute AREs and proteins that can bind to them. So far no 
binding specificity could be inferred between ARE binding proteins (ARE-BPs) and AREs, 
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with many ARE-BPs found to bind multiple AREs and some AREs found to interact with 
multiple ARE-BPs. The variety of possible interactions hints at a level of functional 
redundancy or antagonism for ARE-BPs in regulating RNA stability (Raineri et al., 2004), 
and it has been hypothesised that the fate of an ARE-containing RNA is dependent on the 
relative levels of stabilising and destabilising ARE-BPs recruited to it (Barreau et al., 2005). 
Intriguingly, AREs were also shown to have a role in regulating translation. AREs on the 
3’UTR of IFN-β, c-Fos and GM-CSF mRNAs were found to have an inhibiting effect in 
translation that is independent from RNA degradation (Grafi et al., 1993; Grosset et al., 2004; 
Kruys et al., 1989).  
The first identified ARE-BP to have an effect on RNA stability is Auf1, which directs RNA 
decay via a protein complex consisting of dimers of itself together with other factors such as 
eIF4G, Pabp and heat shock proteins hsc70-hsp70 (Laroia et al., 1999), although subsequent 
studies revealed that Auf1 could also increase RNA stability (Xu et al., 2001). Other well-
studied ARE-BPs include the Hu family, which includes HuR/HuA, Hel-N1, HuC and HuD. 
Binding of  HuR, Hel-N1 and HuD increases stability of their target mRNAs (Ford et al., 
1999; Jain et al., 1997; Mobarak et al., 2000). As an example, hypoxia induced stability of 
VEGF mRNA occurs via HuR binding (Levy et al., 1998).  
The main mechanisms in which mRNA is degraded in mammalian cells starts with 5’ 
decapping or 3’ deadenylation. Transcription of mRNAs from RNA polymerase II is 
followed by capping of the 5’end with modified nucleotides and prevents it from being 
accessed by 5’ exonucleases. Decapping of the 5’end by the decapping enzymes Dcp1/2 
precedes 5’-3’ exonucleolytic decay by the 5’-3’ exoribonuclease Xrn1. On the other hand, 
transcription is followed by polyadenylation of the 3’ end of most mammalian mRNAs. The 
3’ ends are cleaved at specific polyadenylation sites, where then a long poly(A) tail is added 
by the poly(A) polymerase Pap1, and the tail is bound by poly(A)-binding protein (Pabp) 
(Görlach et al., 1994). The poly(A) tail confers a stabilising effect to the mRNA, likely via 
blocking the assembly of the exosome complex on the 3’ end, which contains exonucleases 
(Ford et al., 1997; Wilson and Treisman, 1988). Evidence suggests that both degradation 
from both ends of an mRNA could occur simultaneously, with 3’ deadenylation followed by 
5’ decapping (Couttet et al., 1997).  
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Figure 3: General mRNA degradation pathways. mRNAs to be degraded first undergo Deadenylation. This is 
followed by decapping by Dcp1/2 and 5’ to 3’ degradation by Xrn1, or recruitment of the exosome complex to 
the 3’ end and 3’ to 5’ degradation. Adapted from (Decker and Parker, 2012). 
 
1.5.4 RNA granules: Sites for RNA storage and degradation 
 
Within the cell, mRNPs are sometimes assembled into very large protein-containing 
structures called RNA granules that are microscopically visible. Depending on their main 
protein constituents, RNA granules are classified into a few distinct types, some of the most 
studied being stress granules (SGs) and processing bodies (P-bodies), and they serve various 
purposes in RNA metabolism.  
SGs, as their name suggests, are accumulated during cell stress, when mRNAs being 
translated are redirected from polysomes to these cytoplasmic foci (Kedersha and Anderson, 
2007). Assembly of SGs are highly anti-correlated with translation and the assembly of 
ribosomes. It is initiated by phosphorylation of eukaryotic initiation factor 2α (eIF2α), which 
is also a step in blocking translation initiation (Kedersha et al., 1999). In addition, SG 
assembly is increased by puromycin induced disassembly of ribosomes, and reduced by 
emetine stabilisation of ribosomes (Kedersha et al., 2000). These findings, together with the 
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fact that SGs contain components of the translation initiation machinery, indicates that 
mRNAs could shuttle between translating ribosomes and SGs. mRNAs in SGs are not 
degraded (Laroia et al., 1999), thus they serve as a site for temporary storage of mRNAs. 
While assembly of PBs is also driven by cell stress and they share certain proteins with SGs, 
they differ in that PBs do not contain translation initiation components but RNA degradation 
components, such as the decapping enzymes Dcp1/2 and the 5’-3’ exoribonuclease Xrn1 
(Kedersha et al., 2005), and are sites for RNA degradation (Parker and Sheth, 2007). 
It has recently been shown that mRNAs could be transferred between these two (Kedersha et 
al., 2005; Wilczynska et al., 2005). It is thus hypothesised that SGs serve as a temporary 
storage point for mRNAs following translation arrest during cell stress, keeping its cargo 
mRNAs in a translationally repressed state. There the mRNAs wait for signals to either be 
redirected back to ribosomes for reinitiation of translation, or to PBs for degradation. 
 
1.5.5 Cytoplasmic Polyadenylation 
 
Before the discovery of cytoplasmic polyadenylation, it was thought that deadenylation of 
mRNAs would lead to its degradation. But since then, it was found that deadenylated mRNAs 
in the cytoplasm could persist for a long time in a translationally repressed state, and be re-
adenylated for re-initiation of translation. Most of the biochemistry of this cytoplasmic 
polyadenylation was performed in Xenopus oocytes, where a repertoire of maternal mRNAs 
exists, in a deadenylated and “dormant” state, and are reactivated upon meiotic progression. 
Subsequent studies over the last decades have broadened the systems where cytoplasmic 
polyadenylation is known to occur to include mitotic cell cycle progression, senescence, 
tumourgenesis, synaptic plasticity (Richter, 2007; Villalba et al., 2011). As an example of 
cytoplasmic polyadenylation contributing towards temporal changes in protein expression, 
about 20% of proteins in the mouse liver that undergoes rhythmic protein expression from 
circadian control have a corresponding change in poly(A) tail length that precedes the change 
in expression (Kojima et al., 2012). 
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Cytoplasmic polyadenylation is mediated by the motif cytoplasmic polyadenylation element 
(CPE) located in the 3’UTR, its binding protein Cpeb1, and a hexanucleotide (hex) with the 
canonical sequence AAUAAA. Upon completion of transcription, a group of factors 
including the cleavage and polyadenylation specificity factor (Cpsf) mediate the cleavage of 
the pre-mRNA at 20-30 bases 3’ of the hex motif, and add a long poly(A) tail of 200-250 
bases to it (Mandel et al., 2006; Sachs and Wahle, 1993). Following nuclear export, mRNAs 
that contain CPE are recognised by Cpeb1, which recruits a protein complex consisting of the 
scaffold protein Simplekin, the deadenylase Parn and the poly(A) polymerase Gld2. Parn and 
Gld2 have antagonistic activities, but Parn is more active than Gld2, and when both are 
present the net effect is a shortening of poly(A) tail (Barnard et al., 2004; Kim and Richter, 
2006). As a result this complex removes much of the poly(A) tail from  CPE-containing 
mRNAs, and they remain in a translationally repressed state in the cytoplasm. It has even 
been proposed that Cpeb1 already binds to its target mRNAs before their nuclear export, to 
ensure tight translation repression (Lin et al., 2010).  
Activation of these dormant mRNAs involves phosphorylation of Cpeb1 at Ser174 by the 
kinase Aurora A (Sarkissian et al., 2004). This expels PARN from the complex, allowing 
Gld2 to elongate the poly(A) tail (Kim and Richter, 2006). Upon poly(A) tail lengthening, 
poly(A) binding protein (Pabp) binds to the poly(A) tail, and recruits eIF4G to eIF4E on the 
5’ cap of the mRNA. This leads to circularisation of the mRNA, which is one of the 
processes during translation initiation (Wells et al., 1998). 
In addition to Cpeb1, the RBP Pumilio (Pum) was also found to influence cytoplasmic 
polyadenylation and subsequent translation. Pumilio interacts with Cpeb1 in Xenopus 
oocytes and represses translation of cyclin B1 mRNA (Nakahata et al., 2001, 2003). This was 
found to be mediated in conjunction with Cpeb1, with a combinatorial code stemming from 
the arrangement of CPE, hex and the binding domain of Pum (PBE) on the 3’UTR of the 
mRNA determining polyadenylation and translation (Piqué et al., 2008). 
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Figure 4: Regulation of cytoplasmic polyadenylation by Cpeb1. mRNAs are polyadenylated after transcription. 
Upon nuclear export, mRNAs with CPEs are targeted by a Cpeb1-containing protein complex. The opposing 
actions of the poly(A) polymerase Gld2 and the deadenylase Parn results in shortening of the poly(A) tail, as 
Parn has higher activity. Upon phosphorylation of Cpeb1 by the kinase Aurora A, Parn is expelled, leading to 
elongation of the poly(A) tail by Gld2. Adapted from (Richter, 2007). 
 
1.5.6 Regulation of translation at initiation 
 
 
Regulation of translation occurs principally at the initiation stage, rather than during 
elongation or termination (Jackson et al., 2010). For the majority of mRNAs, this occurs via a 
mechanism dependent on the 5’ cap structure of the mRNA, and is referred to as cap-
dependent translation (Merrick, 2004). At the onset of translation initiation, a ternary 
complex that consists of methionine-loaded initiator tRNA and GTP-coupled eIF2 is formed. 
This complex binds to the 40S small ribosomal subunit and other initiation factors to form the 
43S pre-initiation complex. eIF4A unwinds secondary structures in the 5’UTR of the mRNA, 
and the 43S complex is recruited to the cap structure of the circularised mRNA via binding of 
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eIF3 to eIF4G, which then scans the mRNA in a 5’ to 3’ direction for the initiator AUG 
codon (Lamphear et al., 1995). Recognition of the initiator codon is assisted by eIF1 and 
eIF1A, and upon reaching it a stable 48S initiation complex is formed (Pestova et al., 1998). 
Subsequently, eIF5 and eIF5B promotes the hydrolysis of the eIF2-bound GTP, displacing 
the eIFs and recruiting the large 60S ribosomal subunit. Together the large and small subunit 
form the 80S initiation complex, and the Met-tRNA base pairs with the initiator codon 
(Gebauer and Hentze, 2004; Poulin and Sonenberg, 2013). 
Regulation of initiation mainly occurs via impacting the eIFs. The best studied examples is 
changing the active states of eIF2α and eIF4E binding proteins (4E-BPs) via phosphorylation. 
Phosphorylation of the α subunit of eIF2 dissembles eIF2 from eIF2B and prevents GDP-
GTP exchange, thus inhibiting translation. 4E-BPs is a group of 3 functionally equivalent 
proteins that normally bind to eIF4E, which prevents its association with eIF4G and thus the 
recruitment of the 43S pre-initiation complex to the mRNA. Upon phosphorylation of 4E-
BPs, usually via mTOR signalling, they are released from eIF4E, allowing association of 
eIF4E with eIF4G and subsequent translation initiation (Gebauer and Hentze, 2004; Jackson 
et al., 2010).   
 
1.5.7 Local protein translation and retrograde transport of axonally synthesised 
proteins 
 
The temporal and spatial control over gene expression provided by cytoplasmic 
polyadenylation is important for localised translation, as mRNAs have to be translationally 
suppressed before they are transported to their destination and translation is required. The 
advantages offered by localised protein synthesis are especially important to neurons, whose 
axons and dendrites are far removed away from the cell soma. For proteins needed for a 
quick response, for example those needed in growth cones to respond to environmental cues 
to navigate the growth direction of the axon, to synthesise the protein in the cell soma and 
transport them to the axonal or dendritic tip would take too long. A similar case could be 
argued for functioning of synaptic connections (Jung et al., 2012). 
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Indeed, axons severed from the cell body are capable of growth and correct pathfinding, 
confirming the presence and role of axonal mRNA translation (Harris et al., 1987). One of the 
first precise functions identified for axonal translation is mediating the chemotropic response 
induced by Netrin-1 and Sema3A in Xenopus retina, where isolated axons continue to 
respond to these signals, but is blocked when translation is inhibited (Campbell and Holt, 
2001). Application of Netrin-1 and Sema3A increases phosphorylation of eIF4e and 4EBP 
and also incorporation of radioactively labelled amino acids (Campbell and Holt, 2001). In 
addition, local protein synthesis in the axonal and dendritic compartments is also necessary 
for neurotrophin-mediated plasticity by Bdnf and NT-3 in the hippocampus (Kang and 
Schuman, 1996). Synaptic plasticity and memory consolidation was also found to depend on 
dendritic synthesis of CaMKIIα (Huber, 2000; Miller et al., 2002).  
As would be expected, local translation is also involved in injury response of axons. 
Regenerating growth cones of axons of adult sensory neurons were found to contain 
translational initiation factors, ribosomal proteins and rRNAs. The ability to form growth 
cones in regenerating axons were found to be affected by treatment with protein synthesis 
inhibitors cycloheximide and anisomycin, even when the cell soma has been removed, 
demonstrating that translation does occur in axons and is involved in growth cone formation 
(Verma et al., 2005). 
Some of the best studied axonally translated genes are importins, which are mediators of 
retrograde transport. Retrograde transport allows far ends of axons and dendrites to 
communicate with the cell soma, for example in case of an injury. Importins are mainly 
localised in axons, and a lesion up-regulates them by means of local translation in sciatic 
nerves. Disruption of importin-mediated nuclear translocation by treating the site of axotomy 
with synthetic peptides containing the nuclear localisation signal (NLS) inhibits regrowth of 
DRG axons (Hanz et al., 2007). In particular, mRNA of Importin-β1 was found to localise in 
axons via its 3’UTR, and axonal knockout of Importin-β1 attenuates the transcriptional 
response and regrowth after axotomy of DRG neurons (Perry et al., 2012). 
Besides injury, retrograde transport also plays a role in neuron specification. In certain cases, 
when axons meet their targets, they encounter target-derived signalling molecules which 
induce specification of the neuron. In one such system, target-derived Bdnf induces 
translation of axonally localised Smad1, 5 and 8 RNAs, which are then translocated to the 
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cell soma where they are phosphorylated into transcriptionally active forms (Ji and Jaffrey, 
2012).  
 
 
Figure 5: Overview of various post-transcriptional regulation mechanisms of gene expression. Recognition of 
3’UTR motifs (e.g. zip-code, AREs, CPE) by various binding partners influences subcellular localisation, 
stability and polyadenylation of the mRNA. Length of the poly(A) tail in turn affects stability. Translation 
initiation is affected by polyadenylation status, 5’UTR elements, and the phosphorylation status of 4E-BPs and 
eIF2α. Adapted from (Baker and Coller, 2006). 
 
1.6 Aims of study 
 
Axons of the adult mammalian CNS have very limited ability to regenerate following an 
injury. For this reason, SCI often leads to drastic and pro-longed disabilities. Despite 
numerous studies conducted in the past decades, our understanding on what prevents 
regeneration in the CNS is still very limited, and a robust therapy to improve axon 
regeneration and functional recovery after SCI is yet to be found. Studies have recently 
started to show increasing evidence of the importance of post-transcriptional control in 
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protein expression, as well as the role of localised protein synthesis in axons towards axonal 
physiology. We hypothesise that post-transcriptional regulation plays an extensive role in the 
injury response of CNS neurons, and that by modulating post-transcriptional regulation, CNS 
neurons could be reprogrammed to regenerate. 
 
Thus, the first goal of this project is to perform genome-wide profiling to uncover the extent 
of post-transcriptional regulation of gene expression upon SCI and its functional relevance. 
The second goal is to investigate major RBPs players of this regulatory process and whether 
CNS regeneration could be improved via manipulating these candidate RBPs, and to 
elucidate through which mechanisms these RBPs influence the fate of their target mRNAs. 
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2. Materials and Methods 
 
2.1 Materials 
 
2.1.1 Chemicals and Reagents 
 
Chemical / Reagent / Kit Source 
4% Paraformaldehyde in phosphate buffer Roth 
Acid-Phenol:Chloroform, pH 4.5 (with IAA, 
125:24:1) 
Ambion 
Actinomycin Sigma-Aldrich 
Agar Roth 
Agarose Sigma-Aldrich 
Agencourt Ampure XP beads Life Technologies 
Agilent high-sensitivity DNA kit Agilent 
Amicon-Ultra-15 column (100K MWCO) Sigma-Aldrich 
Ampicillin AppliChem 
AXIS Axon isolation devices, 450um Millipore 
B27 supplement (50X), serum free Thermo Fisher Scientific 
Benzonase Millipore 
Boric acid Fluka 
Caesium chloride (CsCl) Sigma-Aldrich 
Calcium chloride (CaCl2) Sigma-Aldrich 
cOmplete Protease Inhibitor Cocktail Tablets Roche 
Cordycepin Sigma-Aldrich 
Cycloheximide (CHX) Sigma-Aldrich 
D(+)-Glucose  Sigma-Aldrich 
Diethyl pyrocarbonate (DEPC) Sigma-Aldrich 
Dithiothreitol (DTT) Sigma-Aldrich 
DNA gel loading dye (6X) Thermo Fisher Scientific  
dNTP mix Fermentas 
Dulbecco’s Phosphate buffered saline (PBS) 
(Mg
2+
 and Ca
2+ 
free) 
PAA 
Dulbecco's Modified Eagles Medium 
(DMEM)  
Life Technologies 
EDTA Thermo Fisher Scientific 
Egg albumin Gerbu 
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Ethanol (EtOH) Sigma-Aldrich 
FailSafe PCR Enzyme Mix Epicentre 
Fetal bovine serum Biochrom 
Fluoroblok cell culture insert, PET 
membrane, 3um pores 
Corning 
Fluoromount-G eBioscience 
G2 Dialysis Cassette (20K MWCO, 15ml) Thermo Fisher Scientific 
GeneChip Mouse Genome 430A 2.0  Affymetrix 
GeneChip One-Cycle Target Labeling and 
Control Reagents 
Affymetrix 
Glucose Sigma-Aldrich 
Glutamine Life Technologies 
Glycine Sigma-Aldrich 
Glycoblue Ambion 
Goat serum Chemicon 
Hank’s balanced salts solution (HBSS) Life Technologies  
HEPES Gibco 
Horse serum Biochrom 
Isoflurane Baxter 
Isopropanol Sigma-Aldrich 
KAPA HiFi HotStart ReadyMix KAPA Biosystems 
Ketavet (100mg/ml) Pfizer 
L-Glutamine (100x L-Glutamine) Life Technologies 
Millicell hanging inserts, PET membrane, 
3µm pores 
Millipore 
Minimum essential medium (MEM) Thermo Fisher Scientific 
N2 supplement (100X) Thermo Fisher Scientific 
Nextera XT DNA Sample preparation kit Illumina 
Nextera XT Index kit Illumina 
Nonidet P-40 Roche 
Oligonucleotide primers MWG 
PCR H2O  Braun 
Penicillin Streptomycin (P/S) Life Technologies 
Phenylmethanesulfonyl fluoride solution 
(PMSF) 
Sigma-Aldrich 
Poly(A) Tail-Length Assay Kit Affymetrix 
Polyacryl carrier Fisher Scientific 
Polyethylene glycol (PEG) solution  Sigma-Aldrich 
Poly-L-lysine hydrobromide Sigma-Aldrich 
Potassium chloride (KCl) Applichem 
Potassium phosphate monobasic (KH2PO4) Gerbu 
Pure Link Hi Pure Plasmid Filter Maxiprep Life Technologies 
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Kit 
QIAmp Micro DNA isolation kit Qiagen 
Quantitect primers Qiagen 
Qubit dsDNA high-sensitivity (HS) kit Life Technologies 
Ribo-Zero Magnetic Kit Epicentre 
RNAqueous-Micro kit Ambion 
RNase-free H2O Ambion 
RNase-free PBS Ambion 
RNasin Plus RNase Inhibitor (RNAsin) Promega 
Rompun (2%) Bayer 
Round glass cover slips Roth 
ScriptSeq Index PCR Primers Epicentre 
ScriptSeq v2 RNA-Seq Library Preparation 
Kit 
Epicentre 
Sodium acetate  Ambion 
Sodium azide  Merck 
Sodium chloride (NaCl) Sigma-Aldrich 
Sodium deoxycholate (DOC) Sigma-Aldrich 
sodium dihydrogen phosphate (NaH2PO4) Sigma 
Sodium dodecyl sulfate (SDS) Roth 
sodium hydrogen phosphate (Na2HPO4) Sigma 
Sodium pyruvate 
 
Thermo Fisher Scientific 
Sodium tetraborate (Borax) Sigma-Aldrich 
Sucrose  Sigma-Aldrich 
SuperFrost slides Roth, Germany 
Superscript II reverse transcriptase Life Technologies 
SuperScript VILO cDNA Synthesis Kit Life Technologies 
SYBR® Green PCR Master Mix Applied-Biosystems 
Tools for mouse surgery Fine Science Tools 
Triton X-100 Sigma-Aldrich 
Trizma base Sigma-Aldrich 
Trypsin-EDTA (0.05%) Life Technologies 
TSO oligonucleotide Exiqon 
Tween-20 Merck 
Ultracentrifuge tubes Beckman Coulter 
Table 1: List of chemicals and reagents 
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2.1.2 Solutions and Media 
 
Solutions Composition 
Perfusion solution 5.71mg/ml Ketavet  
2.8mg/ml Rompun  
in NaCl 0.9% 
PBS (20X) 
 
160g/L NaCl 
23g/L Na2HPO4 
28.84g/L NaH2PO4 
4g/L KCl 
4g/L KH2PO4 
 
Fill up to 1L with H2O and adjust pH to 7.4 
TBS (10X) 
 
24.23g/L Trizma base 
80.06g/L NaCl 
 
Fill up to 1L with H2O and adjust pH to 7.6 
DEPC H2O 1:1000 DEPC 
 
Prepare in H2O, leave overnight and autoclave 
2X Gradient buffer 30mM Tris-HCl pH7.4 
30mM MgCl2 
600mM NaCl 
200μg/ml cycloheximide (CHX) 
2mM dithiothreitol (DTT) 
 
Prepare in DEPC H2O and sterile filter 
Light sucrose gradient solution 8.67 g sucrose,  
25 ml 2X Gradient buffer 
 
Fill up to 50 ml with DEPC H2O 
Heavy sucrose gradient solution 25g sucrose 
25ml 2X Gradient buffer 
 
Fill up to 50 ml with DEPC H2O 
  
 
 
 
 
Homogenisation buffer 0.25M sucrose 
50mM Tris/HCl, pH7.4 
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5mM MgCl2 
25mM KCl 
 
Prepare in DEPC H2O and sterile filter. Add the 
following just before use: 
200μg/ml CHX 
1X Roche complete protease inhibitor 
1mM DTT 
1mM PMSF 
100U/ml RNAsin 
0.9M sucrose solution 30.8% sucrose 
50mM Tris-HCl, pH7.4 
5mM MgCl2 
25mM KCl 
 
Prepare in DEPC H2O and sterile filter. Add the 
following just before use: 
100 μg/ml CHX 
1X Roche complete protease inhibitor 
1mM DTT 
1mM PMSF 
1.1M sucrose solution 38.5% sucrose,  
50mM Tris-HCl, pH7.4  
5mM MgCl2 
25mM KCl 
 
Prepare in DEPC H2O and sterile filter. Add the 
following just before use: 
100μg/ml CHX 
1X Roche complete protease inhibitor 
1mM DTT 
1mM PMSF 
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2M sucrose solution 68.4% sucrose 
50mM Tris-HCl, pH7.4 
5mM MgCl2 
25mM KCl 
 
Prepare in DEPC H2O and sterile filter. Add the 
following just before use: 
100μg/ml CHX 
1X Roche complete protease inhibitor 
1mM DTT 
1mM PMSF 
Benzonase buffer 50mM TrisHCl  
2mM MgCl2  
150mM NaCl 
 
adjust pH to 8.5 and autoclave 
Na-HEPES resuspension buffer 50mM HEPES 
0.15M NaCl 
25mM EDTA 
 
Prepare in H2O and sterile filter  
CsCl topping solution 0.55g/ml CsCl 
 
Prepare in Na-HEPES resuspension buffer  and 
adjust refractive index to 1.3710 at room 
temperature 
40% PEG8000/1.915M NaCl 
solution 
40% v/v PEG  
1.915M NaCl  
 
Sterile filter 
Borate buffer 1.24g boric acid 
1.9g sodium tetraborate (Borax) 
 
Adjust to 400ml with H2O, adjust pH to 8.5 and 
sterile filter 
PLL coating solution 1mg/ml poly-L-lysine  
 
Prepare in borate buffer and sterile filter 
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HS-MEM 10% horse serum 
1.2% glucose 
2mM glutamine 
1mM sodium pyruvate 
0.22% NaHCO3 
1X Penicillin Streptomycin 
1X MEM 
 
Prepare in H2O and sterile filter 
N2-B27-MEM 1X N2 supplement 
1X B27 supplement 
0.1% w/v egg albumin 
0.6% glucose 
1mM glutamine 
1mM sodium pyruvate 
0.22% NaHCO3 
1X Penicillin Streptomycin 
1X MEM 
 
Prepare in H2O and sterile filter 
Table 2: List of solutions and media 
 
2.1.3 Antibodies 
 
Antibody Conjugate Host species Manufacturer Dilution 
Primaries antibodies 
Cpeb1 ptg  Rabbit Proteintech 1:250 
Cpeb1  Mouse Group of Raúl Méndez 1X 
β-tublin  Mouse Millipore 1:300 
Secondary antibodies 
Anti-rabbit 488 Alexa 488 Goat Life Technologies 1:500 
Anti-mouse 488 Alexa 488 Goat Life Technologies 1:500 
Anti-mouse 633 Alexa 633 Goat Life Technologies 1:500 
Table 3: List of antibodies 
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2.1.4 Primers 
 
Gene Primer 5’-3’ sequence 
Apc qPCR-F TGCAGGCCATTGCAGAGTTA 
 qPCR-R ACACAGCGTAGCCTTGTTGG 
c-Fos qPCR-F CGACCATGATGTTCTCGGGT 
 qPCR-R GCGCAAAAGTCCTGTGTGTT 
c-Jun qPCR-F TGGGCACATCACCACTACAC 
 qPCR-R TCTGGCTATGCAGTTCAGCC 
Cebpb qPCR-F ATCCGGATCAAACGTGGCTG 
 qPCR-R GGCCCGGCTGACAGTTAC 
Cpeb1 Genotyping-F AGATGCAAATGGCTTGTGCC 
 Genotyping-R GGCCATCTCTTTGGAGCACT 
Cpeb4 qPCR-F TATGGGCGAAGGAGAGGTCAG 
 qPCR-R AGGTGACCCCAGACCACTAT 
 PAT-F1 ACTGTGTATGGGGAGGTTGT 
 PAT-F2 AGCAAGTGGGTGTCTAGTTT 
 PAT-F3 TCCTCTTTCTTGCTGGTGTT 
 PAT-utrR CCACTAGCACTTCAACAAATGA 
Ctnnb1 qPCR-F TACGAGCACATCAGGACACC 
 qPCR-R AAAGCAACTGCACAAACAATGG 
 PAT-F1 TTTATCGGGGATACGTGCGG 
 PAT-F2 AGCAGGTGGATCTATTTCATGTTTT 
 PAT-F3 AGACGTGTAACATTGTGTAGCCT 
 PAT-utrR CCGCATCTGTTGAAGCATTGT 
Egr1 qPCR-F CACCTGACCACAGAGTCCTTTT 
 qPCR-R GACTAGGCTGAAAAGGGGTTCA 
Fosb qPCR-F CGACTTCAGGCGGAAACTGA   
 qPCR-R TTCGTAGGGGATCTTGCAGC   
Gapdh qPCR-F CCAGTGAGCTTCCCGTTCA 
 qPCR-R GAACATCATCCCTGCATCCA 
Junb qPCR-F CAACCTGGCGGATCCCTATC 
 qPCR-R GCCTGTGTCTGATCCCTGAC 
Kif5c qPCR-F AAGAGGCCAAGGAGAATGCC 
 qPCR-R GATGGGCTTGGCGATCTGAG 
Kpnb1 qPCR-F AGGGCGGAGATCGAAGACTA 
 qPCR-R TGGTACCAGATCAAGCCTGG 
 PAT-F1 AGCATCAATCTGTAATTGGCATTCA 
 PAT-F2 AGAAGAAGTTCAAATTCCATCCACT 
 PAT-F3 GACTGGAGAAGTGGAGGGAC 
 PAT-utrR AAGGTGGTGGTATCAGTTTTGG 
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Map2k7 qPCR-longutr –F AAGCTACTTGAACACAGCTTCATC 
 qPCR-longutr-R CATGAGGCTACCTGAAGAAGGG 
 qPCR-shortutr-F AAGCTACTTGAACACAGCTTCATC 
 qPCR-shortutr-R CAGACTCCCACTGAAGAAGGG 
Nfkbia qPCR-F CTCTTGTTGAAATGTGGGGCTG 
 qPCR-R CAGTCATCATAGGGCAGCTCAT 
Pten qPCR-F GCATCGGGGCAAATTTTTAAAGGCA 
 qPCR-R GGATTGCAAGTTCCGCCACTGA 
 PAT-F1 ACCAAAGTTGGAGTTGTGGA 
 PAT-F2 AGCCTCTTGATGTGTGCATT 
 PAT-F3 CCCACTGGGATTTTACAGTTT 
 PAT-utrR TCCACAGGAAGGTATTTCTAGTC 
Socs3 qPCR-F TAGACTTCACGGCTGCCAAC 
 qPCR-R CGGGGAGCTAGTCCCGAA 
Stat3 qPCR-F ACCCAGGTAGTGCTGCCCCGTA 
 qPCR-R GGGGGACATCGGCAGGTCAAT 
 PAT-F1 ACTGCACTCAGATTCCAATGTA 
 PAT-F2 ACTGCTTAGCCTTTCAGTGC 
 PAT-F3 GAACAAGGTGAGGGCTTCTC 
 PAT-utrR CTGGAAGTTAAAGTAGTTACAGCA 
Stxbp1 qPCR-F AGGAGCTCAGCAAGTATTCGAC 
 qPCR-R GGATGGGGACAATGGCTCTC 
Table 4: List of primers 
 
qPCR primers for Map2k7 (total), Neurod2, Noggin, and Zfp36l2 were purchased as 
QuantiTect Primers from QIAGEN. 
 
2.2 Methods 
 
2.2.1 Animal experiments 
 
2.2.1.1 Mice 
 
Mice were housed under standard conditions and fed ad libitum. All procedures were in 
accordance to the DKFZ guidelines and approved by the Regierungpräsidium Karlsruhe. 
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C57BL/6J mice, referred to as “wild-type” hereinafter, were bred in house at the DKFZ 
Center for Preclinical Research facility. Cpeb1
flox/flox 
mice were kindly provided by Raúl 
Méndez. 
 
2.2.1.2 Spinal cord injury 
 
Female C57BL/6 mice of age 10-12 weeks were used. Females were chosen due to ease of 
emptying the bladders of injured animals. Mice were anesthetised by exposure to 3% 
isofluran in oxygen. Concentration is then reduced to 1.5% to maintain anesthesia. The back 
of the animal was shaved and a 1cm incision was made on the skin along the middle. The 
vertebral column was exposed by separating the surrounding fat and connective tissues. A 
laminectomy was performed at thoracic level T7/8 to reveal the spinal cord, which is then 
symmetrically transected with fine irridectomy scissors. The surrounding tissue was then 
sutured and the skin closed with surgical clamps. Sham operation were performed in the same 
way but without transecting the spinal cord. Bladders of injured animals were depressed and 
emptied once a day. 
 
2.2.1.3 Perfusion 
 
Animals were anesthetised by injection of 200ml of perfusion solution. The thoracic cavity 
was then opened to reveal the heart, and the animal perfused by transcardial perfusion with 
20ml of HBSS. If tissues are to be extracted for immunohistochemistry, this is followed by 
10ml of 4% PFA. 
 
2.2.1.4 Drosophila experiments 
 
Drosophila experiments were performed by Marta Koch from the lab of Bassem Hassan. 
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Fly stocks and genetics 
 
Drosophila melanogaster stocks were kept on standard cornmeal media. For tissue specific 
overexpression of the transgenes, the GAL4/UAS system was used (Brand and Perrimon, 
1993). pdf-gal4, uasgfp; pdf-gal4, uas2x egfp/cyo flies were used to drive expression of the 
various candidate genes, or crossed to wild-type Canton S (CS) for the outgrowth 
experiments, or to UAS-lacZ for the regrowth experiments. Overexpression stocks were 
obtained from the Bloomington Stock Centre and the pdf-gal4 line was obtained from P. 
Taghert. Flies were dissected 2-10 days after eclosion. 
Drosophila outgrowth and regrowth assays 
 
For the outgrowth screening, a minimum of 5 fly brains (10 sLNv projections) per genotype 
were dissected in PBS, fixed in 4% PFA and stained with for Gfp. The degree of sLNv 
outgrowth was classified as “increased”, “reduced” or “no observable effect” relative to that 
of controls. 
 
Regrowth assay was performed on whole brain explants as described (Ayaz et al., 2008; 
Koch and Hassan, 2012). Briefly, flies were reared at 18°C to minimize developmental 
effects, and shifted to 25°C one day prior to injury. Culture plate inserts were coated with 
laminin and PLL. Fly brains were dissected in a sterile Petri dish containing ice cold 
Schneider’s Drosophila Medium (GIBCO) and transferred to a culture plate insert containing 
culture medium (10 000 U/ml penicillin, 10 mg/ml streptomycin, 10% Fetal Bovine Serum 
and 10 µg/ml insulin in Schneider’s Drosophila Medium). sLNv axonal injury was performed 
using an ultrasonic microchisel controlled by a powered device (Eppendorf), and dishes were 
kept in a humidified incubator at 25°C. Four days later, cultured brains were fixed and 
stained for Gfp. The exact location of the lesion was determined by comparison with axonal 
projection length at 5 hours post-injury when regrowth has not yet occurred. Injured sLNv 
neurons that has formed at least one new axonal sprout with a minimum length of 12µm was 
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measured in ImageJ. Regenerated length was defined as the regenerated axon lengths 
measured using the manual tracing tool. Projected distance was defined as the displacement 
of the axon sprouts from the lesion site, measured in a straight line. Statistical comparisons 
were performed with student’s t-test. 
 
2.2.2 Tissue and cell biology 
 
2.2.2.1 Cortical neuron culture 
 
Cortical neuron isolation 
 
Mice were put together overnight for mating and then separated. At embryonic day 16.5, the 
mother was sacrificed by cervical dislocation and the embryos were removed. Embryonic 
brains were extracted in cold HBSS with 1% P/S and cortices were dissected under a 
dissection microscope in a mouse hood. Cortices were washed once with HBSS with 1% P/S, 
then incubated in 0.5ml 0.05% trypsin at 37ºC for 5 minutes. Trypsination was stopped by 
adding 1 volume of HS-MEM. Cortices were washed once in HS-MEM and then triturated 
with flame polished glass Pasteur pipettes until a cell homogenate is formed. The cell 
suspension was then centrifuged at 2000G for 3 minutes at 4ºC and resuspended in HS-
MEM. Cells were then counted with a counting chamber, mixed with AAV if needed, and 
plated accordingly. 
 
Plating 
 
For culturing neurons on glass cover slips or microscopic slides (for AXIS devices), the 
culture surface was immersed in concentrated nitric acid (65%) overnight, washed 5 times 
with deionised water, dried and sterilised by ultraviolet light irradiation in a cell culture hood 
for 20 minutes. PLL coating solution was added to cover the whole surface, incubated at 37ºC 
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overnight, and washed 2 times with deionised water before use. Transwell culture inserts 
were coated in the same way but without the acid treatment and UV sterilisation. 
Cover slips and transwell chambers were placed into tissue culture plates with wells of fitting 
sizes and neurons suspended in HS-MEM were added.  
For AXIS devices, the device was placed and attached to microscopic slides just before use. 
Cells were resuspended in 5µl and dispensed directly into the channel on the cell soma side. 
The soma side wells were then filled with medium, followed 5 minutes later by axon side 
wells, to allow time for medium to pass through the microgrooves to the axon side and 
prevent bubbles from blocking the groove openings. Cells were then plated as follows: 
 Number of cells Volume of medium 
18mm round cover slip (12 well) 3x10
5
 1ml 
12mm round cover slip (24 well) 1x10
5
 0.5ml 
Transwell cell culture insert (12 
well) 
3x10
5
 0.5ml upper side, 
1.5ml lower side 
Fluoroblok cell culture insert (24 
well) 
1x10
5
 0.3ml upper side, 
0.7ml lower side 
AXIS 1x10
5
 200µl soma side 
100µl axon side 
Table 5: Number of neurons plated and volume of medium  
Cultures were kept in a humidified cell culture incubator at 37ºC. One day after plating, the 
HS-MEM was replaced with N2B27-MEM.  
 
2.2.2.3 Cell culture 
 
HEK293T cells were maintained in DMEM supplemented with 10% FBS, 1% P/S and 1% L-
glutamine. When confluent, the culture flasks were washed one with PBS. The cells were 
dissociated with 0.25% Trypsin–EDTA at 37ºC. Trypsination was stopped by addition of 1 
volume of culture medium. Cells were washed off the culture surface and pelleted by 
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centrifugation at 4ºC at 1500rpm for 3 minutes. Cells were resuspended in new culture 
medium, splitted and plated accordingly. 
 
2.2.2.4 Adeno-associaded virus (AAV) Production 
 
AAV production was performed in collaboration with the research group of Dirk Grimm, 
who provided the plasmids and protocols and did the initial rounds of virus production.  
 
Transfection 
 
30 15cm cell culture dishes were seeded with 4.5x10
6
 HEK293T cells. 2 days later cells were 
co-transfected with three plasmids: 1) pSSV9-CAG-CreGfp, which contains a Cre Gfp fusion 
under a CAG promoter, flanked by viral ITR sequences for packaging; 2) AdH, which 
contains the helper factors from adenovirus essential for activating the AAV gene expression 
programme; and 3) Wdc2, which contains rep and cap2 that encode AAV replication factors 
and serotype type 2 capsid proteins respectively. 
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Figure 6: Plasmids used in AAV production. A) pSSV9-CAG-CreGfp, expressing a Cre Gfp fusion protein 
under the CAG promoter. 2) AdH, expressing the adenovirus helper factors. 3) Wdc2, expressing replication 
factors and serotype type 2 capsid proteins. 
 
A DNA solution was prepared from 440ug of each plasmid, mixed with 23.7ml of 300mM 
NaCl and filled up to 47.4ml with H2O. Then 1.7ml PEI (2ug/ul) was mixed with 23.7ml of 
300mM NaCl and filled up to 47.4ml with H2O. The PEI solution was then added dropwise 
into the DNA solution. The mixture was vortexed and left to stand at room temperature for 10 
minutes. Then 3.2ml of the mixture was added dropwise onto each plate while swirling the 
medium constantly.  
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Cell lysis and AAV precipitation 
 
3 days after transfection, cells were harvested by scraping and all the culture medium was 
also collected in order to also save detached cells. The cell suspension was pelleted by 
centrifugation at 400G for 15 minutes, washed once with PBS, and resuspended in 15ml 
benzonase buffer. Cells were then lysed by freeze-thawing. The tube was immersed in liquid 
nitrogen for 5 minutes, then transferred to a 37ºC water bath until the cell suspension is 
completely thawed. The process is repeated 4 times. In order to digest host cell DNA and 
RNA, the tube was sonicated for 80 seconds, and benzonase was added to a concentration of 
50U/ml and incubated for 1 hour at 37ºC with vortexing at 10 minutes intervals. Debris was 
then pelleted by centrifugation at 4000G for 15 minutes and the supernatant was collected. 
Subsequently proteins were precipitated by addition of calcium chloride to a final 
concentration of 25mM, incubation on ice for 1 hour and centrifugation at 10,000G at 4ºC for 
15 minutes. The supernatant was collected and AAV was precipitated by addition of ¼ 
volume of 40% PEG8000/1.915M NaCl and incubation at 4ºC for 3 hours.  
 
Caesium chloride (CsCl) purification 
 
The tube was centrifuged at 2500G at 4ºC for 30 minutes and the supernatant was discarded. 
The pellet was resuspended in 10ml Na-HEPES resuspension buffer and incubated overnight 
at 4ºC. The tube was then centrifuged at 2500G at 4ºC for 30 minutes, the supernatant was 
collected and the volume brought up to 24ml with Na-HEPES resuspension buffer and 13.2g 
of CsCl was added. The refractive index (RI) was then measured using a refractometer. RI of 
the virus sample was adjusted to 1.3710 by adding Na-HEPES resuspension buffer when it is 
too high and CsCl when it is too low. Meanwhile the RI of topping solution is adjusted in the 
same manner. The virus sample was then transferred to an ultracentrifuge tube and the tube 
was filled to the top with CsCl topping solution. The tubes were balanced and centrifuged 
with a SW70Ti rotor at 45,000rpm at 21ºC for 22 hours. Subsequently the bottom of the tube 
was punctured with a needle and the contents were separated into 0.5ml fractions starting 
from the bottom by draining into 15ml tubes, while taking care to maintain the sequence of 
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the fractions. The RI of the fractions were measured and those with RI within 1.3711 and 
1.3766 were pooled.  
 
Dialysis and concentration 
 
The virus solution was dialysed to exchange caesium chloride with PBS using a G2 Dialysis 
Cassette (20K MWCO, 15ml). The cassette was first equilibrated by immersing in PBS for 2 
minutes. The volume of the virus sample was brought up to 9ml with PBS and added into the 
cassette. The cassette was first immersed in cold PBS and kept at 4ºC without stirring and the 
PBS replaced after 30 minutes for better removal of caesium chloride. Stirring was started 
after the first PBS replacement. PBS was replaced again after 1 hour, 2 hours, 2 hours, 
overnight, and 2 hours.  
An Amicon-Ultra-15 column (100K MWCO) was then used to concentrate the virus. The 
filter on the column was first equilibrated by washing 2 times with 15ml PBS and 
centrifugation at 1000G for 2 minutes. Virus sample was applied to the column and 
centrifuged at 400G until a volume of 1-1.5ml was reached. The AAV sample was collected, 
aliquoted and stored at -80ºC. 
 
Titration 
 
Virus samples were lysed by alkaline lysis. 10µl of virus aliquot was mixed with 10µl TE 
buffer and 20µl 2M NaOH and incubated at 56ºC for 30 minutes. Then the lysis was stopped 
by addition of 38µl 1M HCl and diluted with 922µl H2O. qPCR together with serially diluted 
standards was performed and the titer of the sample was deduced by plotting a standard 
curve.  
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2.2.2.5 Drug treatment  
 
Actinomycin was added to the culture medium to a final concentration of 10µM. For 
transwell chambers, the medium from both compartments were pooled, actinomycin was 
added, and the medium was redistributed to both compartments. For AXIS cultures, the 
medium was removed from the axon side. Then medium containing 200µM of cordycepin or 
cycloheximide was dispensed back into the axon side channel and wells. 
 
2.2.2.6 Regeneration assays 
 
For cultures on cover slips, a glass Pasteur pipette was drawn across the culture surface to cut 
processes. For transwell chambers, the underside of the Fluoroblok cell culture inserts were 
scraped with a sterile cotton swap to remove the processes growing there. For AXIS cultures, 
vacuum was applied directly to the axon side channel to suck away the axons.  
For cultures on cover slips and AXIS devices, the cultures were imaged live with a phase 
contrast filter. For transwell chamber cultures, the live cell dye Calcein AM was added to the 
medium 30 minutes before imaging and processes are visualised using a Gfp filter. Imaging 
was performed using a Zeiss Cell Observer from the DKFZ Light Microscope Core Facility. 
Images were analysed and regenerating processes were traced with ImageJ in a blinded 
manner. In order to ease the effort for tracing and reduce subjective biases, a custom written 
ImageJ macro kindly provided by Damir Krunic from the DKFZ Light Microscope Facility 
was used for supervised automated tracing. Firstly, the rollerball function was applied to 
equalise background signal. Gaussian blur was then applied to smooth out any part of the 
processes with weak signal, which would otherwise be considered as a break. Then a 
threshold was manually set to subtract the background signal while minimising the breaks 
created in the processes. The skeletonise and analyse particles functions were used to trace all 
the processes, with a lower limit of 60 pixels to discount debris. Comparison of data from 
manually and macro traced images revealed the two to be highly similar to each other. 
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Figure 7: Supervised automated tracing of neuronal processes. A) Input from stitched tile scan images. B) 
Background signal across tiles is equalised and subtracted. C) Processes are skeletonised and traced. D) 
Tracings superimposed on the original image. 
 
2.2.2.7 Immunohistochemistry 
 
Extracted tissues were fixed with 4% PFA at 4ºC overnight. After washing 2 times with PBS, 
tissues were sectioned using a vibrotome to appropriate thicknesses and kept in PBS with 
0.02% sodium azide at 4ºC until use. Sections were washed 3 times 15 minutes each in TBS, 
then blocked with TBS supplemented with 0.25% Triton X-100 and 3% serum (TBS++) for 1 
hour. Primary antibody was diluted in TBS++ and incubated with the sections overnight at 
4ºC with shaking. Afterwards the sections were washed 3 times 15 minutes each with TBS, 
and incubated with secondary antibody diluted in TBS++ at room temperature for 2 hours 
with shaking. The sections were then washed again with TBS 3 times 15 minutes each, and 
finally mounted on glass slides with Fluoromount-G and left to dry in the dark.  
 
 42 
 
2.2.3 Molecular biology 
 
2.2.3.1 DNA Extraction 
 
DNA was isolated using the QIAmp DNA Micro kit from QIAGEN according to the 
manufacturer’s protocol. 180µl of Buffer ATL was added to neurons grown on cover slips 
and lysis was assisted with a cell scrapper. The lysate was transferred to a 1.5ml tube. 20µl 
Proteinase K was added and the tube was incubated at 56ºC for 45 minutes. 200µl Buffer AL 
containing 1µl of polyacryl carrier was then added to each sample, followed by 200µl of 
100% ethanol. The tube was then incubated for 5 minutes at room temperature, and the lysate 
was transferred to a QIAamp MinElute colutm and centrifuged at 6000G at room temperature 
for 1 minute. The flow-through was discarded, and the column was washed with 500µl 
Buffer AW1 and then with 500µl Buffer AW2. The column was centrifuged a further 3 
mintues to dry the membrane completely. To elute the DNA, 30µl of nuclease-free water was 
added to the membrane, the column was incubated at room temperature for 1 minute, then 
centrifuged at full speed for 1 minute. 
 
2.2.3.2 Polysome fractionation 
 
Sucrose gradient preparation 
 
Heavy and light sucrose gradient solutions were prepared and added to the corresponding 
chambers of the gradient maker with magnetic stirrers. The gradient maker is placed on a stir 
plate on an elevated platform and the output was connected to a glass capillary placed at the 
bottom of an ultracentrifuge tube.  The valves were then opened to allow the sucrose 
solutions to mix and flow into the tube via gravity, starting with light sucrose. The sucrose 
solution that comes out becomes denser over time, and displaces the lighter sucrose upwards, 
thus generating a gradient in the tube. The gradients were prepared at least 1 hour before 
fractionation and kept at 4ºC until use. 
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Tissue preparation 
 
Animals were anesthetised and perfused with 20ml of HBSS supplemented with 0.2mg/ml 
cycloheximide which immobilizes ribosomes on associated transcripts. Tissues were 
extracted to homogenisation buffer (40µl for brains and 10µl for spinal cords) on ice and 
diced into small pieces to allow better penetration of cycloheximide and incubated for at least 
15 minutes. Tissue pieces were then homogenised with a Dounce tissue grinder with specific 
number of strokes (5 times with a tight pestle for brains, 5 times with a loose pestle followed 
by 5 times with a tight pestle for spinal cords) to disrupt cells while keeping the nuclei intact. 
20% volume of the lysate is fresh frozen for later extraction of total RNA. Nuclei and tissue 
fragments were pelleted and removed by centrifugation at 500G at 4ºC for 10 minutes. 
Remaining membrane fragments in the supernatant were lysed by addition of NP-40 and 
sodium deoxycholate detergents to a final concentration of 1% each. 
 
Myelin floatation 
 
Fatty components mainly coming from myelin in the samples have to removed or the signal 
in the polysome profile might be masked. The lysate is first mixed with 1.22 volumes of 2M 
sucrose solution and transferred to a polyethylene ultracentrifuge tube, and filled up to 
approximately 10ml volume with 1.1M sucrose solution. Then 0.9M sucrose solution is 
carefully overlaid on top to the rim of the tube. Subsequently the tubes were centrifuged with 
SW40Ti rotor and buckets at 24,000rpm at 4ºC for 3 hours. During this step fatty lipids float 
up and ribosomes are deposited as a pellet at the bottom. 
 
Sucrose gradient fractionation 
 
The supernatant was carefully removed completely without disturbing the pellet, and the 
pellet was resuspended in 400µl homogenisation buffer supplemented with 1% NP-40 and 
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1% sodium deoxycholate. The samples were then carefully overlaid on top of sucrose 
gradients, and centrifuged at 40,000rpm at 4ºC for 1.5 hours. The gradients were then 
fractionated using an Isco density gradient fractionator. The UV detector was switched on at 
least 15 minutes before fractionation to allow the UV lamp to warm up and set to the 
appropriate sensitivity (0.2 for brains, 0.05 for spinal cords). The tube piercer was assembled 
and connected to 60% sucrose solution via a rotating pump. The setup was tested by pumping 
for a few minutes to ensure there were no leaks in the connections. Water was pumped into 
the UV detector with a syringe and baseline was set to an appropriate level.  
The ultracentrifuge tubes containing the samples was carefully attached to the UV detector 
and pierced from the bottom with the tube piercer. 60% sucrose solution was then pumped 
from below to slowly displace the samples upwards into the UV detector and into the drop 
dispenser. The absorbance at 260nm was recorded to generate the absorption profile for the 
sample. The samples were collected in 0.5ml fractions and frozen at -80ºC until use. 
 
2.2.3.3 RNA Extraction 
 
Neurons 
 
Due to the small amount of material available from neuron cultures, the RNAqueous-Micro 
kit is used following the manufacturer's instructions. Cover slips were washed briefly with 
PBS, then 300µl of Lysis Solution was added. The cover slips were then scraped using a cell 
scrapper and the lysate transferred to a 1.5ml tube. If RNA is to be extracted from either 
processes or cell soma from transwell chambers, then the side not needed was scraped with a 
DNAse- and RNAse-free cotton swap (when extracting processes, the upper surface was 
scraped, when taking cell soma, the lower surface was scraped). The membrane was then cut 
out with a scalpel, rinsed briefly in PBS, then put into a 1.5ml tube containing 300µl Lysis 
Solution and vortexed. Subsequently 150µl of 100% ethanol was added and the tube was 
vortexed. The lysate was then loaded into a Micro Filter Cartridge Assembly and centrifuged 
using a table-top centrifuge at full speed for 10 seconds, and the flow-through was discarded. 
The cartridge was washed once with 180µl of Wash Solution 1, then 2 times with 180µl of 
 45 
 
Wash Solution 2/3, with full speed centrifugation for 10 seconds in between. The cartridge 
was centrifuged at full speed for a further 1 minutes to remove residue fluid. To elute RNA, 
15µl of 75ºC RNAse-free water was added to the centre of the filter, incubated for 1 minute 
in room temperature, and then centrifuged at full speed for 30 seconds. This step is repeated 
once to increase RNA yield.  
DNA was then removed by DNAse treatment. 3µl of 10X DNAse I buffer and 1µl of DNAse 
I was added to each sample and then incubated at 37ºC for 20 minutes. Afterwards 3.4µl of 
DNAse Inactivation Reagent was added and incubated at room temperature for 2 minutes. 
The tube was centrifuged at full speed for 1.5 minutes, and the supernatant taken and stored 
at -80ºC. 
 
Polysome fractions 
 
To each individual fraction or pooled fractions, 10% SDS was added to a final concentration 
of 1% to unfold proteins and dissociate ribosomes. One volume of acidic phenol chloroform 
was added and the samples incubated at 65ºC for 10 minutes. After centrifugation at 17,000G 
at room temperature for 20 minutes, the aqueous phase was transferred to a new tube. In 
samples with high sucrose concentrations the aqueous phase may be at the bottom due to 
phase inversion. Then 1 volume of isopropanol, 1/9 volume of sodium acetate (pH 5.2) and 
1µl of GlycoBlue was added to each sample and the RNA was precipitated by incubation at -
80ºC for at least 1 hour. The samples were then centrifuged at 17,000G for 30 minutes at 4ºC 
and the supernatant was discarded. The pellet was washed once with 80% ethanol, then air 
dried and dissolved in nuclease-free water. 
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2.2.3.4 Reverse transcription 
 
Reverse transcription was performed using the SuperScript VILO cDNA Synthesis Kit, with 
the following reaction mix and thermo cycle: 
RNA 100-1000ng 
10X SuperScript Enzyme 
Mix 
2µl 
5X VILO Reaction Mix 4µl 
Nuclease-free water To 20µl 
 
 
25ºC 10 minutes 
42ºC 60 minutes 
85ºC 5 minutes 
 
 
 
2.2.3.5 Quantitative Real-time PCR (qPCR) 
 
qPCR is performed using a 7500 Fast Real-Time PCR System Cycler (Applied Biosystems) 
with the following reaction mix: 
H2O 9.7µl 
Forward primer (1:20 diluted) (stock 100µM) 1.8µl 
Reverse primer (1:20 diluted) (stock 100µM) 1.8µl 
2x SYBR Green PCR Master Mix 12.5µl 
cDNA template 1µl 
 
If Qiagen Quantitect primers were used, they were not further diluted. All reactions were run 
as technical triplicates. 
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2.2.3.6 Poly(A) tail (PAT) assay 
 
PAT assay was performed using the Poly(A) Tail-Length Assay Kit from Affymetrix 
according to the manufacturer's protocol. Firstly, a number of guanosine and inosine residues 
were added to the 3' end of the poly(A) tails, to facilitate priming, with the following reaction 
mix: 
DNase-treated RNA 1µg 
5X Tail Buffer Mix 4µl 
10X Tail Enzyme Mix 2µl 
Nuclease-free water To 20µl 
 
The reaction mix was incubated at 37ºC for 60 minutes, and the reaction was stopped by 
adding 2µl of 10X Tail Stop Solution. Next the G/I-tailed RNAs were reverse transcribed into 
cDNA with the following reaction mix: 
 
G/I tailed RNA 5µl 
5X RT Buffer Mix 4µl 
10X RT Enzyme Mix 2µl 
Nuclease-free water 9µl 
 
The reaction mix was incubated at 44ºC for 60 minutes, 92ºC for 10 minutes, and then hold at 
4ºC. cDNA samples were diluted 1 fold with nuclease-free water. Two different PCRs were 
then performed. A "Tail PCR" with primers flanking the poly(A) tail of a specific gene to 
measure the length of the tail, and a "UTR PCR" with primers priming within the 3'UTR as a 
semi-quantitative measure of sample amount. Gene-specific primers were designed to have a 
Tm of 60ºC. At least 3 different forward primers were designed and tested, and the best one 
was picked based on amplification efficiency and specificity. The reaction mix and thermo 
cycle of the PCRs are as follows:  
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 Tail PCR UTR PCR 
Diluted cDNA 2µl 2µl 
5X PCR Buffer Mix 5µl 5µl 
10µM Gene-Specific Forward Primer 1µl 1µl 
10µM Universal Reverse Primer 1µl - 
10µM Gene-Specific Reverse Primer - 1µl 
1.25U/µl HotStart-IT Taq DNA Polymerase 1µl 1µl 
Nuclease-free water To 25µl To 25µl 
 
 
94ºC 2 minutes  
94ºC 10 seconds 
30 cycles 
60ºC 30 seconds 
72ºC 5 minutes  
4ºC hold  
 
PCR products were mixed with loading buffer and run on a 2.5% agarose gel to determine the 
range of poly(A) tail lengths. 
 
2.2.3.7 Microarray 
 
Total and polysome-bound RNA fractions from polysome fraction of spinal cords were 
profiled with microarrays (GeneChip Mouse Genome 430A 2.0, Affymetrix) by Stefan 
Klußman. Input amounts of 5µg and 3µg were used for total and polysome-bound RNA 
fractions respectively. Details of the following steps consisting of cDNA synthesis, in vitro 
transcription, cRNA purification and fragmentation, microarray hybridisation, washing and 
staining, could be found in the thesis of Stefan Klußman. The microarray chips were scanned 
using a HP GeneArray scanner (Affymetrix). 
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2.2.3.8 Library preparation for whole genome RNA-seq from neuronal processes 
 
Library preparation by ScriptSeq protocol 
 
Sample RNAs were first depleted of rRNAs using the Ribo-Zero Magnetic Kit (Epicenter) 
and purified using AMPure XP beads. The quality of the RNA was then checked using a 
Bioanalyzer RNA Pico Chip. RNAseq libraries were then prepared using the ScriptSeq v2 
RNA-Seq Library Preparation Kit (Epicentre) according to the manufacturer’s protocol. 
Briefly, the rRNA-depleted samples were fragmented and subjected to cDNA synthesis. The 
resulting cDNA was tagged at the 3’ end using a Terminal-Tagging Oligo (TTO). The cDNA 
was then purified again with AMPure XP beads, and subjected to 15 cycles of PCR 
amplification with ScriptSeq Index Primers. Finally the amplified cDNA was purified once 
more with AMPure XP beads, quantified with Qubit and ran on a High Sensitivity 
Bioanalyzer DNA Chip to access sample amount and quality. 
 
Library preparation by Smart-seq2 protocol 
 
RNAseq libraries were prepared using the Smart-seq2 protocol as published in (Picelli et al., 
2014). Briefly, 1ng of DNAse-treated RNA from neuronal processes were used as input 
material. Reverse transcription was performed using SuperScript II reverse transcriptase, an 
oligo(dT) primer and a locked nucleic acid (LNA)-containing template-switching 
oligonucleotide. The resulting cDNA was then amplified by 14 cycles of PCR with KAPA 
HiFi DNA polymerase. Amplified cDNA was then purified by 1x volume of AMPure XP 
beads, quantified with Qubit and ran on a High Sensitivity Bioanalyzer DNA Chip to access 
sample amount and quality. 500pg of purified cDNA was then taken for tagmentation and 11 
cycles of amplification using the Nextera XT DNA sample preparation kit (Illumina), after 
which the cDNA is converted into libraries with unique barcodes. After a further cleanup 
using AMPure XP beads at a ratio of 0.6:1, the cDNA libraries were measured with Qubit 
and Bioanalyzer to access again the quality and concentration.  
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Next generation RNA-sequencing 
 
A total of 10 libraries were generated, 3 each from developing and regenerating wild type 
processes, and 2 each from developing and regenerating Cpeb1 knockout processes. 20ng 
from each library were used to create a multiplex, which is measured again with Qubit and 
Bioanalyzer to calculate the final molarity. 
Sequencing was performed at the DKFZ Genomics and Proteomics core facility. Amplified 
cDNA libraries were subjected to 100bp paired-end sequencing with Illumina HiSeq 2000. 
Samples were allocated into 2 lanes so that each sample will exceed the minimal requirement 
of 30 million reads. 
 
2.2.4 Bioinformatics analysis 
 
2.2.4.1 Microarray 
 
Analysis of microarray data was performed by Alvaro Mateos. Array data corresponding to 
each fraction were normalized separately using the vsn method implemented in the 
R/bioconductor package vsn (Huber et al., 2002). lts.quantile=0.5 was used to allow robust 
normalization when many genes are differentially expressed. Differential expression was 
calculated using limma (Smyth, 2004) from R/bioconductor at the level of probesets. The 
threshold for significance was set at Benjamini-Hochberg false discovery rate (FDR) < 0.05. 
Probesets were then translated to Ensembl gene ids (Ensembl v72; www.ensembl.org). 
Probesets mapping to multiple Ensembl gene ids were excluded from subsequent analysis. 
GO enrichment analysis was performed by comparing abundance of annotated GO terms 
among the up- to the down-regulated genes using the GOstats package (Falcon and 
Gentleman, 2007) and the annotation package org.Mm.eg.db v2.14.0 from R/bioconductor. 
The background was defined as the combination of up- and down-regulated groups, while 
excluding any intersections (when multiple probesets mapping to the same gene show both 
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up- and down-regulation). Under-representation of up-regulated genes is displayed as 
enrichment of down-regulated genes. 
To perform the enrichment study in the mouse and fly genomes, GO annotations from the 
R/Bioconductor annotation packages org.Mm.eg.db v2.14.0 and org.Dm.eg.db v2.14.0 were 
used. Only annotations derived from experimental evidence were used, in order to prevent 
circularity when annotations derived from homology are used. To prevent artificially inflating 
the number of motifs when genes have more than one transcript with a common 3'UTR, 
enrichment analysis was performed at the level of genes. 
Cytoscape v3.0.2 (Shannon et al., 2003) was used to visualize the results from the enrichment 
analysis. Only significant terms (Benjamini-Hochberg FDR < 1
-4
) were shown on the GO 
network, with each node referring to a GO category. The colour represents the direction of 
enrichment, with the colour intensity and size of the node representing significance of 
enrichment. 
To associate fold changes from transcripts to motifs in their 3'UTR, probesets were translated 
to Ensembl transcript id (Ensembl v72), and only probesets that map to a single unique 
transcript were used. 3'UTR sequences were obtained from Ensembl v72 and searched for 
sequences of the investigated RNA motifs. Distributions of fold change were compared using 
the Kolmogorov-Smirnov test (http://cran.r-project.org/). To represent the fold change 
profiles for transcripts from specific GO categories, we used GO annotation at the level of 
transcript from the R/Bioconductor tool biomaRt. 
 
2.2.4.2 RNA-seq 
 
Computational analysis of RNAseq data was performed in collaboration with Sheng Zhao. 
Quality of raw reads was checked by FASTQClllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Adapter sequences in raw reads 
were trimmed with Btrim64 (http://graphics.med.yale.edu/trim ) (Kong, 2011). Trimmed 
reads were then mapped to mouse genome GRCm38 (ENSEMBL v78) using STAR_2.4.0g 
(Dobin et al., 2013) and quantified with HTSeq 0.6.1p2 (Anders et al., 2014). RNAseq data 
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quality metrics, such as total number of reads, transcriptome mapped reads and mapping rate 
were calculated by picard-tools-1.123 (https://broadinstitute.github.io/picard/).  
Gene expression matrices were generated as previously described in (Shalek et al., 2013). 
Briefly, expression level of each gene was quantified by transcript per million (TPM) and 
fragments per kilobase of transcript per million fragments mapped (FPKM) using RSEM 
1.2.18 (Li and Dewey, 2011). 
Principal component analysis (PCA) was performed using custom developed R scripts based 
on FactoMineR library (http://factominer.free.fr/) using counts. GO and KEGG pathway 
enrichment analysis was performed using the the tool Metascape (http://metascape.org/) with 
default parameters. Genes with calculated log2FC > 0.75 or < -0.75 and an adjusted p-value < 
0.05 were used as input and the whole genome was used as background. Bonferroni 
correction of the hypergeometric p-value was used to calculate statistical significance of the 
enrichment. Upstream Regulator Analysis from Ingenuity (QIAGEN) was used to look for 
upstream regulators of gene expression, which makes the prediction based on the input gene 
list and their corresponding fold change.Genes with calculated log2FC > 0.75 or < -0.75 and 
an adjusted p-value < 0.05 were used as input, and ran with default parameters. 
 
2.2.4.3 Dynamic analyses of Alternative PolyAdenylation from RNA-Seq (DaPars)  
 
Analysis of alternative polyadenylation (APA) events in the RNAseq data using DaPars (Xia 
et al., 2014) was performed by Mechthild Lütge. 
Briefly, an extended gene model was applied, which extends the 3’UTRs of annotated genes 
by 10kb until a neighbouring gene is reached. The RNAseq data was then annotated using 
this model. Each 3’UTR was then scanned in a 5’ to 3’ direction, and a drop in reads 
coverage, defined as having < 5% of the coverage of the previous exon, is considered as a 
distal polyA site. A regression model is then used to identify the location of a proximal polyA 
site. Relative poly(A) site usage is indicated by Percentage of Distal poly(A) site Usage Index 
(PDUI), which is calculated by: 
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Where WL and WS are the estimated expression levels of transcripts with usage of distal and 
proximal poly(A) site respectively. Statistical test for significance for differential polyA site 
usage between conditions is performed using Fisher’s exact test and adjusted using 
Benjamini-Hochberg false-discovery rate (FDR). APA is considered to occur in a gene 
between two conditions (X and Y) when a) FDR ≤ 0.05; b)                   ; and c) 
      
     
     
     
 
2.2.5 Statistical analyses 
 
Statistical tests used varied according to the type of data and are specified in the respective 
figures. All analyses were performed in Prism 5.0 (Graphpad) or in R (http://cran.r-
project.org/). 
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3. Results 
 
3.1 Uncoupling of transcription and translation in injury response of the 
CNS 
 
3.1.1 Widespread uncoupling between transcriptional and translational responses to 
SCI 
 
To simultaneously profile the transcriptional and translational response to neuronal injury in 
the mammalian CNS, translational state array analysis (TSAA) was performed in our group 
by Stefan Klußmann (Fig. 8A). A time point of 9 hours after SCI was chosen, which is during 
the early phase after injury where axons are attempting to regenerate (Cajal et al., 1991; 
Kerschensteiner et al., 2005). The time point is also desirable as the infiltration of immune 
cells is still limited (Gadani et al., 2015; Hausmann, 2003), and that there is enough time for 
transcriptional and translational changes to take place (Schwanhäusser et al., 2011). TSAA 
was performed by isolating total and polysome-bound RNAs from the same injured or naïve 
spinal cords. Polysome-bound RNAs were isolated by sucrose gradient fraction (Lou et al., 
2014) and collecting fractions that contain more than one ribosome. The different pools of 
sample RNAs were then subjected to microarray analysis. Changes in the total RNAs and 
polysome-bound RNAs represent changes in mRNA abundance and ribosome-loading 
respectively. Bioinformatics data analysis was performed by Alvaro Mateos. 
As expected, a large number of genes were found to be differentially expressed upon SCI 
(Fig. 8B). In the total RNA fraction, there are slightly more genes that are up-regulated than 
down. In the polysome-bound RNA fraction, there are a lot less differentially regulated 
genes, with the majority of them being down-regulated. This agrees with the notion that upon 
stress, there is a general shut down of translation to maximise cell survival (Park et al., 2008; 
Yamasaki and Anderson, 2008). For many genes, there is a discrepancy between the direction 
of change in mRNA abundance and ribosome loading (Fig. 8C and D), and the correlation 
between the two is low (R = 0.036). This suggests strong and widespread uncoupling 
between transcriptome and translatome response of SCI. 
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Figure 8: Spinal cord injury induces uncoupled changes in mRNA abundance and ribosome loading. A) 
Experimental scheme of TSAA of mouse naïve and injured spinal cord. n=3 mice per group. B) Number of 
differentially expressed genes upon injury in mouse spinal cord from different RNA fractions with false 
discovery rate (FDR) < 0.05. Chi-square of distribution of up- and down-regulated genes in total and polysome-
bound RNA fractions: p < 0.0001. C) Fold changes in total and polysome-bound RNA upon spinal cord injury. 
D) Heat map representation of gene expression with z-score in total and polysome-bound RNA from naïve and 
injured mice spinal cords. Each column represents one biological replicate and each row represents the same 
gene across lanes. (Data by Stefan Klußman and Alvaro Mateos) 
 
3.1.2 Functional clustering of uncoupled genes 
 
To investigate the functional relevance of this uncoupling effect, Gene Ontology (GO) 
analysis (Ashburner et al., 2011) was performed for biological processes (BP) GO categories 
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and visualized using Cytoscape (Shannon et al., 2003). The different pattern of GO 
enrichment of up- and down-regulated genes in the total and polysome-bound RNA fractions 
suggests that uncoupling is functionally relevant (Fig. 9). mRNA abundance for genes related 
to RNA processing and splicing, ribosome biogenesis, translation and protein localisation 
were increased upon SCI; and genes related to CNS development, neurogenesis, neuron 
differentiation and cytokine responses were decreased (Fig. 9A). On the other hand, ribosome 
loading for genes related to inflammatory and cytokine response, cell death regulation and 
transcription was increased (Fig. 9B). Interestingly, no enrichment of down-regulated genes 
in ribosome bound RNAs was observed, suggesting the decrease in translation is a general 
effect and not specific to any particular function. Of particular note, CNS development genes 
have reduced mRNA abundance upon SCI but their ribosome loading remained similar. This 
suggests a preferential translation of these genes, possibly underlying the temporary 
regeneration at this phase after SCI. The down-regulation of mRNA abundance could explain 
the later termination of regeneration, as these mRNAs are not replenished when they reach 
the end of their lifespan. 
 
 
Figure 9: Functional clustering of the injury response in the A) total and B) polysome-bound RNA fractions. 
Each node represents one GO category. Enrichments of up- and down-regulated- genes are indicated as red and 
blue nodes respectively. Colour intensity and size of the node represent significance by FDR. (Data by Stefan 
Klußman and Alvaro Mateos) 
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3.1.3 Uncoupled genes regulate axonal growth in Drosophila 
 
 
To investigate if transcripts exhibiting this uncoupled behaviour do indeed affect axonal 
growth, a screening of axonal growth following exogenous expression of candidate genes 
was performed in Drosophila by Marta Koch in the group of Bassem Hassan in VIB, 
Belgium. A list of 38 candidate genes that exhibited uncoupling after SCI, and for which a fly 
homologue exists and a UAS line was available, was chosen. These genes were expressed in 
the small ventral lateral neurons (sLNvs), a population of CNS neurons in the fly brain, using 
the UAS-Gal4 system (Brand and Perrimon, 1993). Most of these genes have reduced mRNA 
abundance but similar ribosome loading upon spinal cord injury (Table 6). It was discovered 
that 19 (50%) tested candidates influenced the developmental growth of the sLNv axonal 
projection, from which 12 increased the outgrowth and 7 had a negative effect (Fig. 10 and 
Table 6). The high proportion of uncoupled genes influencing axonal outgrowth supports the 
notion that uncoupling is functionally related to axonal regeneration. 
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Figure 10: Overexpression of uncoupled genes modifies axonal outgrowth in Drosophila sLNv neurons. A-E) 
Representative pictures of Drosophila brain slice cultures with sLNv neurons overexpressing the indicated 
genes, and the grade given for the degree of axonal outgrowth. F) Number of genes inducing increased, 
decreased or no change in axonal outgrowth. A minimum of 5 brains were quantified per genotype. Scale bars: 
50µm. (Data by Marta Koch) 
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SCI/Naïve fold change 
Phenotype in Drosophila 
overexpression 
Mouse gene 
symbol 
Fly gene 
symbol 
total RNA 
fraction 
polysome-
bound RNA 
fraction 
Axonal outgrowth 
Ankhd1 mask -0.304 0.342 decreased 
Anp32a Mapmodulin -0.075 0.494 decreased 
Bbx bbx -0.363 0.149 decreased 
Lphn1 Cirl -0.023 0.273 decreased 
Ncor1 Smr -0.264 0.347 decreased 
St13 CG2947 -0.055 -0.109 decreased 
Tenm3 Ten-m -0.026 0.218 decreased 
Cdc25a stg -0.092 0.190 increased 
Cpeb1 Orb 0.257 -0.334 increased 
Eif3c eIF3-S8 0.149 0.271 increased 
Prkacb Pka-C1 -0.308 0.165 increased 
Rad50 rad50 0.079 0.111 increased 
Rbfox2 CG32062 -0.209 0.148 increased 
Rhou Cdc42 0.533 0.513 increased 
Sfswap su(wa) -0.331 -0.094 increased 
Trim family Brat NA NA increased 
Txnrd1 Trxr-1 0.020 0.428 increased 
Wnk1 CG7177 -0.254 0.431 increased 
Ywhaz 14-3-3ζ 0.274 -0.270 increased 
Atrx XNP -0.343 0.192 no observable effect 
Aurka Aur -0.064 0.109 no observable effect 
Bptf e(Bx) -0.062 0.381 no observable effect 
Brd2 fs(1)h -0.038 0.555 no observable effect 
Chd4 Mi-2 -0.279 0.362 no observable effect 
Ctcf CTCF -0.085 0.126 no observable effect 
Eif2c2 Ago1 NA NA no observable effect 
Gnrhr GRHR -0.173 0.029 no observable effect 
Kif5b Khc -0.120 0.050 no observable effect 
Lpin2 CG8709 -0.174 0.284 no observable effect 
Magi2 Magi -0.560 0.316 no observable effect 
Mll3 CG5591 -0.848 -0.016 no observable effect 
Naa15 Nat1 0.314 0.099 no observable effect 
Nedd4 Nedd4 -0.246 -0.072 no observable effect 
Nr4a2 Hr38 0.079 0.032 no observable effect 
Rest crol -0.309 0.126 no observable effect 
Trip12 CG17735 0.075 0.228 no observable effect 
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Vps35 CG5625 0.044 0.009 no observable effect 
Wdfy3 bchs -1.076 0.547 no observable effect 
Table 6: List of genes screened for effects on Drosophila sLNv axonal outgrowth and fold changes in TSAA. 
(Data by Marta Koch and Stefan Klußman) 
 
3.2 Identification of RNA motifs that regulates uncoupling behaviour 
 
3.2.1 Association of 3’UTR motifs with smaller reductions in mRNA abundance upon 
SCI 
 
In order to uncover the mechanisms of post-transcriptional regulation leading to uncoupling 
behaviour of transcripts, the association of common features in the 3’UTR of the mRNA to 
its expression in the RNA fractions from TSAA was investigated. Many regulatory motifs 
reside within the 3’UTR and govern the dynamics of the mRNA, such as degradation, 
transport and translation (Moore, 2005; Szostak and Gebauer, 2013). In addition, many 
neuronal mRNAs crucial to axon physiology such as Gap43, β-actin, Map2 and Bdnf are 
regulated via their 3’UTRs (Blichenberg et al., 1999; Donnelly et al., 2011; Lau et al., 2010). 
The analysis has to be performed on the transcript level, since transcript variants of the same 
gene can have different 3’UTRs. To this end, data from probesets that map to only one 
transcript was used.  
The motifs studied here are the cytoplasmic polyadenylation element (CPE), Pumilio binding 
element (PBE), Musashi binding element (MBE), and the hexanucleotide (Hex) which is 
involved in polyadenylation. The change in mRNA abundance after SCI was more positive 
for mRNAs that contain the studied motifs versus those that do not (Fig. 11A). Specifically, 
mRNAs that do not possess the motif in question suffer a greater decrease in the total RNA 
fraction than those that do possess it. In contrast, no significant difference is observed in 
changes in the polysome-bound fraction upon SCI (Fig. 11B). To ensure that this is not an 
artefact, the analysis was repeated using the same motifs but on the 5’UTR (Fig. 12A) or 
random sequences between 5 and 9 base pairs long (Fig. 12B), and no association with 
changes in mRNA abundance was observed. These results suggest that these motifs within 
the 3’UTR confer increased transcript stability upon injury. 
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Figure 11: Transcripts possessing specific motifs in their 3’UTR have higher mRNA abundance upon spinal 
cord injury. Density plot of fold changes in the A) total and B) polysome-bound RNA fraction of transcripts 
possessing the indicated motifs versus those that do not. Comparison of similarity between curves: 
Kolmogorov-Smirnov test. (Data by Stefan Klußman and Alvaro Mateos) 
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Figure 12: Lack of association of motifs in the 5’UTR and random motifs towards changes in mRNA 
abundance. A) Density plot of fold changes in the total RNA fraction of transcripts possessing the indicated 
motifs in the 5’UTR versus those that do not. B) Density plot of fold changes in the total RNA fraction of 
transcripts possessing the indicated random motifs in the 3’UTR versus those that do not. Comparison of 
similarity between curves: Kolmogorov-Smirnov test. (Data by Stefan Klußman and Alvaro Mateos) 
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3.2.2 Association of CPE with smaller reductions in mRNA abundance upon SCI in 
regeneration and mRNA processing genes 
 
Special attention was paid to CPE, as it has been shown to play a role in neuron physiology, 
including synaptic plasticity and dendritic transport (Hake and Richter, 1994; Lin et al., 2009; 
Wu et al., 1998), and its exogenous expression increases axonal outgrowth in Drosophila 
sLNv (Fig. 10B). To investigate this in depth, the association of CPE with differential 
expression in the total RNA fraction was repeated in specific GO categories. The association 
of CPE with a smaller decrease in mRNA abundance upon SCI was found to be conserved for 
transcripts of genes related to CNS development, axon development and cell morphogenesis 
(Fig. 13A). This effect is likewise not observed in ribosome loading (Fig. 13B). In addition, 
for RNA processing categories, transcripts containing CPE show a general increase upon 
injury, compared to the stable level of those that do not. This agrees with a recent study that 
RNA repair and splicing pathways regulate axon regeneration (Song et al., 2015). 
To address this, the motif analysis was also performed for AU-rich elements (AREs), which 
regulate RNA degradation or stability. In a similar manner to CPE, transcripts containing 
AREs are less down-regulated in the total RNA fraction following injury (Fig. 14A). Also 
CPE and AREs were found to co-occur in the mouse transcriptome, suggesting the two 
motifs function in conjunction with each other (Fig. 14C). Transcripts possessing both 
elements likewise show higher changes in mRNA abundance than those that do not (Fig 
14D). Taken together, this data suggests that CPE confers stability in mRNA abundance 
against the global decrease induced by SCI, possibly by increasing RNA stability in 
conjunction with AREs.  
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Figure 13: Transcripts possessing CPE in the 3’UTR have higher mRNA abundance in GO categories of CNS 
development, axon development, cell morphogenesis and mRNA processing. Density plot of fold changes in the 
A) total and B) polysome-bound RNA fraction of transcripts with and without CPE in their 3’UTR. Comparison 
of similarity between curves: Kolmogorov-Smirnov test. (Data by Stefan Klußman and Alvaro Mateos) 
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Figure 14: AREs are associated with CPE and a lesser decrease in fold change in the total RNA fraction after 
spinal cord injury. A) Density plot of fold changes in the total RNA fraction of transcripts possessing the 
indicated ARE versus those that do not. B) Density plot of fold changes in the polysome-bound RNA fraction of 
transcripts possessing the indicated ARE versus those that do not. C) Number of transcripts harbouring CPE and 
AUR in the whole transcriptome. Chi-square test of distribution: p < 0.0001. D) Density plots of fold changes in 
the total and polysome-bound RNA fractions of transcripts possessing both AUR and CPE versus those that do 
not. Comparison of similarity between curves: Kolmogorov-Smirnov test. (Data by Stefan Klußman and Alvaro 
Mateos) 
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3.2.3 Conserved enrichment of CPE in nervous system development genes between 
mouse and Drosophila genomes 
 
In order to investigate the general role of CPE, GO enrichment analysis was performed on 
protein coding genes of the mouse and fly genomes. Only GO annotations based on 
experimental evidence were used, in order to exclude annotations derived from evolutionary 
homology which will create circularity when comparing two species. Of the categories 
enriched for CPE containing genes, many relate to nervous system development, including 
neuron projection morphogenesis, axonogenesis and axon guidance (Fig. 15A). In 
Drosophila, CPE-enriched categories are more prevalent, and the association with nervous 
system development genes is stronger (Fig. 15B). Interestingly, CPE-enriched categories 
encompass almost all of those enriched in the mouse genome, suggesting a high level of 
conservation of CPE function between the two species. 
  
Figure 15: Functional clustering of CPE containing genes in the mouse and Drosophila genomes. Each node 
represents one GO category. Over- and under-representation is represented as red and blue respectively. Colour 
intensity and size of the node represent significance. (Data by Alvaro Mateos) 
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3.3 Cpeb1 is a conserved enhancer of neuronal regeneration 
 
3.3.1 Lack of satisfactory Cpeb1 antibodies limits potential experiments 
 
Since CPE is associated with axon regeneration and regulation of RNA dynamics, the next 
logical step would be to study Cpeb1 expression in neurons and localisation to growth cones, 
and to identify target mRNAs of Cpeb1. Immunohistochemical staining of transected spinal 
cords shows enriched signal in the tips of severed axons from wild-type mice (Fig. 16A). 
However, subsequent validations on brains from Cpeb1 full knockout mice, also using other 
antibodies, showed that the staining is non-specific (Fig. 16B and C). Despite a number of 
antibodies against Cpeb1 being available commercially or otherwise, none of them are 
satisfactory, showing no or highly unspecific immunoreactivity. This likewise renders RNA 
immunoprecipitation experiments unreliable (data not shown). This is intriguing as these 
antibodies were raised using peptides from different regions of Cpeb1. This could be due to 
the conformation of Cpeb1 being delicate or unstable, or having a high similarity with other 
proteins. Studies conducted so far on Cpeb1 in neurons mostly made use of RNA in situ 
hybridization or Cpeb1-Gfp fusion proteins (Wilczynska, 2005; Lin, 2009). 
 
Figure 16: Stainings with Cpeb1 antibodies. A) Proximal end of wild-type transected spinal cord 9 hours after 
injury. B and C) Dendate gyrus stainings from Cpeb1 full knockout mice. ptg ab: antibody from ProtinTech; 
RM ab: antibody provided by the group of Raúl Méndez. 
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3.3.2 Generation of Cpeb1 knockout mouse neuronal cultures 
 
In order to investigate the effects of Cpeb1 in mammalian CNS regeneration, a system 
inducing deletion of Cpeb1 in primary cultures of mouse embryonic cortical neurons was 
established. Transgenic mice with exon4 of Cpeb1 floxed were obtained from the group of 
Raúl Méndez. Cre-mediated recombination will remove the floxed exon, introducing a 
frameshift. Domains affected by the frameshift include the RNA recognition motifs (RRMs) 
and activating phosphorylation site, which would cripple the essential functions of the 
protein. Cre was introduced via AAV of serotype 2 expressing a Cre-Gfp fusion protein 
under a CAG promoter, which was produced in collaboration with Elena Senis from the 
group of Dirk Grimm in the University of Heidelberg.  
Neuronal cultures were prepared from cortices of E16.5 mouse embryos and plated on poly-
L-lysine treated surfaces (Kaech and Banker, 2006), and experiments were performed 
between 6 to 8 days in culture, when the neurons have matured. Due to potentially high 
stability of Cpeb1 protein when involved in RNP complexes, infection was performed as 
early as possible. To achieve this, initially AAVs were injected in utero to the ventricles of 
E14.5 embryos and Gfp-expressing cells from the cortex were isolated at E16.5. However 
Gfp positive cells were found to be very dispersed in the cortex (Fig. 17A). An attempt was 
made to isolate these cells with FACS sorting. However the Gfp positive population 
constituted only about 0.5% of the total population and were too few for any experiments 
(data not shown). Subsequently, infections were performed in vitro during neuron plating. A 
range of moiety of infection (MOI) was tested for infection efficiency. The lowest MOI that 
produces a near complete infection was determined to be 1x10
5
. PCR with primers flanking 
exon4 indicated high efficiency of deletion (Fig. 17B).  
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Figure 17: Efficiency of different strategies to produce Cpeb1 knockout neurons. A) Gfp signal from infected 
cells within E16.5 cortices with AAV-CAG-Cre-Gfp injected into ventricles at E14.5. B) Efficient deletion of 
Cpeb1 as detected by PCR from DIV6 cultured cortical neurons, with or without addition of AAV during 
plating. Expected sizes: floxed: 884bp; deleted: 186bp 
 
3.3.3 Knockout of Cpeb1 inhibits regeneration in processes of mouse cortical neurons 
 
Regrowth assay was initially performed on primary cultures of embryonic cortical neurons 
grown on glass cover slips. A glass capillary was drawn across cover slips at 6 days in vitro 
(DIV) to induce injury.  The scratched area was imaged 24 hours later, and neuronal 
processes that have regrown into the tract were traced and measured (Fig. 18A-C). The 
number and length of the regenerated processes were not found to be significantly different 
between Cpeb1 knockout and wild-type neurons (Fig. 18D and E). However this model was 
found to be too variable, as it is hard to precisely determine the position of the cut and where 
regeneration starts. Also the presence of debris, from cells destroyed from the scratching, 
influences image quality and tracing. 
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Figure 18: Regrowth assay using cover slips. A) Timeline of experimental setup. B) Schematic representation of 
inducing neuronal injury via scratching. C) Representative image of the scratched area and regenerated 
processes that were being traced. D and E) Number and median lengths of regenerated processes were not 
significantly changed. Each dot represents one cover slip. n = 5 per group. wt: wild-type + AAV; ko: 
Cpeb1
flox/flox
 + AAV. Statistical analyses: Mann-Whitney. Error bars: mean +/- S.E.M. 
 
Another approach based on transwell chambers was thus used, where neuronal processes can 
grow to the underside of the chamber via pores on the membrane (Fig. 19). Injury was 
induced at 7 DIV by gently scraping the underside with a cotton swab and imaging was 
performed 24 hours after injury. Calcein AM, a live cell dye, was applied 1 hour before to 
facilitate imaging (Fig. 19A). The processes were traced with an ImageJ macro provided by 
Damir Krunic from the DKFZ Light Microscope Core Facility. Deletion of Cpeb1 was found 
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to reduce the number of regenerated processes in knockout neurons (Fig. 20B). In addition, 
the lengths of regenerated processes were also reduced (Fig. 20C). 
 
Figure 19: Establishing regrowth assay with transwell chambers. A) Timeline of experimental setup. B) 
Schematic representation of culturing neurons in a transwell culture insert. C-E) Representative images of the 
underside of the transwell chamber with processes labelled by Calcein AM C) before, D) right after and E) 24 
hours after scraping. Dots are signal from the upper side passing through pores on the membrane. Scale bars: 
100µm 
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Figure 20: Knockout of Cpeb1 impairs regeneration in mouse cortical neurons. A) Representative images taken 
from the lower side 24 hours after injury. F,G) Number and median length of regenerated processes are 
decreased upon Cpeb1 knockout. Each data point represents one culture chamber. n=29 per group. Cpeb1 ko: 
Cpeb1
flox/flox 
+ AAV; wt: wild-type + AAV. Scale bars: 100µm. Statistical analyses: Mann-Whitney. Error bars: 
mean +/- S.E.M. 
 
3.3.4 Expression of Cpeb1 in Drosophila sLNv neurons increases axonal regeneration 
 
A regrowth assay was also performed in Drosophila sLNv neurons by Marta Koch from the 
group of Bassem Hassan. Brain slice cultures were prepared from flies with exogenous 
expression of Orb in sLNvs, whose axons were lesioned mechanically injured and the 
regenerative response was quantified after four days (Ayaz et al., 2008) (Fig. 21A).  
Overexpression of Orb was found to increase both the number and length of sprouts 
following axonal injury (Fig. 21B-D).  
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Together, data from the genome enrichment of Cpeb1 and regrowth assays in mouse and fly 
suggests that Cpeb1 enhances neuronal regeneration, and that this function is conserved 
across species. 
 
 
Figure 21: Exogenous expression of Orb (Cpeb1 homolog) enhances axonal regrowth in Drosophila sLNv 
neurons. A) Representative images of sLNv neurons 4 days after axotomy. Arrowheads indicate lesion points. 
B-D) Number, length and displacement from lesion point of regenerated axon sprouts are increased upon Orb 
expression. Each data point represents one brain slice from one fly. n=13 (flies) for Orb+Gfp and 12 for Gfp 
only. Scale bars: 30µm. Statistical analyses: Mann-Whitney. Error bars: mean +/- S.E.M. (Data by Marta Koch) 
 
3.4 Cpeb1 mediates the transcriptome response of neuronal injury 
 
3.4.1 RNA sequencing of injured and naïve processes from Cpeb1 knockout neurons 
 
Previous data has shown that changes in mRNA abundance are associated with regeneration 
after SCI, and that Cpeb1 likely plays an essential role therein. As a result we investigated 
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changes in global mRNA abundance after injury specifically in neuronal processes, as well as 
the effect of Cpeb1 depletion, with next-generation RNA sequencing. RNA from neuronal 
processes was isolated from naïve and injured processes from wild-type and Cpeb1 knockout 
neurons (Fig. 22A). Libraries were prepared with the help of Klara Zwadlo, sequencing was 
performed in the Genomics and Proteomics Core Facility of the DKFZ, and mapping and 
bioinformatics analysis were performed with the help of Sheng Zhao.  
Since Cpeb1 is a known regulator of polyadenylation, random priming was used to generate 
the cDNA library. Thus the ScriptSeq library preparation protocol was used and libraries 
were processed for 100bp paired-end sequencing. However the total mapping rates were very 
low (<35%) (Fig. 22C). The problem probably comes from the low amount of RNA collected 
when the cell somas have to be excluded. 
 
Figure 22: RNAseq of neuronal processes with ScriptSeq protocol. A) Timeline for generating samples for 
RNA-seq. B and C) Total number of reads are satisfactory but mapping rate is very low. n=3 for wild-type and 
n=2 for Cpeb1 knockout samples. 
 
Library preparation was repeated with the Smart-seq2 protocol (Picelli et al., 2014), which 
requires far less input. Although this protocol makes use of primers with a stretch of 30bp 
poly(T)s to select for poly(A)-containing RNAs, it has been shown that few mRNAs have a 
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poly(A) tail shorter than 30bp (Chang et al., 2014; Subtelny et al., 2014). Thus the bias 
against mRNAs with short poly(A) tails would be minimal. Samples were submitted for 
100bp paired-end sequencing as before. 
Quality control metrics shows great improvement over the ScriptSeq protocol, with high total 
mapping rates and with mRNAs constituting more than 70% of mapped reads in all samples 
(Fig. 23A-C). Principle component analysis (PCA) shows biological replicates cluster 
together (Fig. 23D). There is no reads coverage on exon 4 of Cpeb1 in the knockout samples, 
showing efficient deletion (Fig. 23E).  
 
Figure 23: Quality control of RNAseq of neuronal processes with SmartSeq2 protocol. A-C) Total number of 
reads, mapping rate and percentage of mRNAs in mapped reads are satisfactory and similar across samples. D) 
PCA shows samples cluster together by replicates. E) Genome tracks of Cpeb1 showing exon 4 is efficiently 
deleted in knockout samples. n=3 for wild-type and n=2 for Cpeb1 knockout samples. wt: wild-type + AAV-
CAG-Cre-Gfp; ko: Cpeb1
flox/flox 
+ AAV-CAG-Cre-Gfp. 
 
 77 
 
3.4.2 Cpeb1 mediates the transcriptome injury response in neuronal processes 
 
Two different approaches in comparing the samples were used to elucidate the role of Cpeb1 
in injury response. In the first approach, injured and naïve samples were compared separately 
for wild-type and Cpeb1 knockout processes (Fig. 24A). It was found that the injury response 
is smaller in Cpeb1 knockout than in wild-type processes, with much less differentially 
regulated genes (Fig. 24B and C), suggesting that the transcriptome response is hindered 
upon Cpeb1 knockout. In addition, most differentially regulated genes in Cpeb1 knockout 
processes are down-regulated (Fig. 24D). On functional clustering, up-regulated genes in 
wild-type processes are enriched in TNFα signalling and the p53 pathway (Fig. 24E). 
Interestingly, down-regulated genes are enriched in dendrite development, neuron projection 
morphogenesis and CNS development. This mimics the decrease of CNS development genes 
in the total RNA fraction after SCI (Fig. 9A), and suggests that this in vitro model serves as 
good surrogate of SCI for studying neuronal intrinsic programs activated upon injury. 
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Figure 24: Injury-induced changes in mRNA abundance is reduced in Cpeb1 knockout processes. A) Schematics 
for the current sample comparison: injured versus naïve in wild-type and Cpeb1 knockout processes. B) Dot plot 
of fold change of genes upon injury in Cpeb1 knockout and wild-type processes. Loess fitness curve shows fold 
changes in wild type are higher than in Cpeb1 knockout processes. C) Number of genes differentially regulated 
upon injury (padj<0.05 and with log2FC either >0.75 or <-0.75). D) Density curve of fold change of genes 
differentially regulated upon injury (padj<0.05). E) Selected enriched GO categories of genes differentially 
regulated upon injury in wild-type processes (padj<0.05 and with log2FC either >0.75 or <-0.75). Statistics: 
Differential expression: Wald test; comparison of similarity between curves: Kolmogorov-Smirnov test; GO 
enrichment: Bonferroni adjusted p-value. 
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To ascertain the role of Cpeb1 in the observed transcriptome response after neuronal injury 
transcripts were separated into CPE-containing and -non-containing ones, and their profiles 
of expression after injury in wild-type processes were investigated. Surprisingly, mRNAs 
containing CPE are less differentially regulated than those that do not contain CPE (Fig. 
25A). Looking more deeply into differentially regulated transcripts, there is no significant 
difference in distribution of fold changes between the two groups (Fig. 25B). Although when 
transcripts are further sub-divided according to the number of CPEs they possess, there is a 
mild trend that transcripts with more CPEs tend to be less down-regulated (Fig. 25C). A 
likely scenario that could explain this phenomenon is that at 24 hours after the injury, indirect 
effects and late response have already become prominent, and direct effects of Cpeb1-CPE 
binding are already diluted out and therefore constitute a small part of the observed changes 
in RNA levels. 
 
Figure 25: Association of CPE with changes in mRNA abundance upon injury. A-B) Density curve of fold 
change of CPE containing and non-containing transcripts upon injury for A) all detected transcripts and B) 
differentially regulated transcripts (padj<0.05). C) Density curve of fold change upon injury for differentially 
regulated transcripts (padj<0.05) segregated according to the number of CPEs possessed. Statistics: Differential 
expression: Wald test; comparison of similarity between curves: Kolmogorov-Smirnov test. 
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The second approach compares differences upon Cpeb1 knockout within injured or naïve 
processes (Fig. 26A). There is a much greater response upon Cpeb1 knockout in injured 
processes than in naïve ones, with many more genes being differentially regulated (Fig. 26B-
D). Thus, Cpeb1 appears to play a much greater role in regeneration. Genes related to nuclear 
import and TNFα signalling are down-regulated upon Cpeb1 knockout (Fig. 26E). 
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Figure 26: Cpeb1 knockout induces greater changes in mRNA abundance in injured processes. A) Schematics 
for the current sample comparison: Cpeb1 knockout versus wild-type in naïve and injured processes. B) Dot plot 
of fold change of genes upon Cpeb1 knockout in naïve against injured processes. Loess fitness curve shows fold 
changes is higher in injured than in naïve processes. C) Number of genes differentially regulated upon Cpeb1 
knockout (padj<0.05 test and with log2FC either >0.75 or <-0.75). D) Density curve of fold change of genes 
differentially regulated upon Cpeb1 knockout (padj<0.05). E) Selected enriched GO categories of genes 
differentially regulated upon Cpeb1 knockout in injured processes (padj<0.05 and with log2FC either >0.75 or <-
0.75). Statistics: Differential expression: Wald test; comparison of similarity between curves: Kolmogorov-
Smirnov test; GO enrichment: Bonferroni adjusted p-value. 
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Transcripts were divided into CPE-containing and -non-containing ones and their distribution 
of fold changes upon Cpeb1 knockout was investigated, to ascertain the role of Cpeb1 
towards CPE containing transcripts in the response to injury. Similar to before, CPE 
containing transcripts are less changed upon Cpeb1 knockout (Fig. 27A). Within 
differentially expressed transcripts, the presence of CPE did not bias towards up- or down-
regulation upon Cpeb1 knockout (Fig. 27B), and there is no clear trend of association 
between fold change and the number of CPEs (Fig. 27C). This could again be explained by 
the time point being too late, with indirect effects of Cpeb1 regulation taking over the 
majority of the observed changes in RNA levels. 
 
 
Figure 27: Association of CPE with changes in mRNA abundance upon Cpeb1 knockout. A-B) Density curve of 
fold change of CPE containing and non-containing transcripts upon Cpeb1 knockout for A) all detected 
transcripts and B) differentially regulated transcripts (padj<0.05). C) Density curve of fold change upon Cpeb1 
knockout for differentially regulated transcripts (padj<0.05) segregated according to the number of CPEs 
possessed. Statistics: Differential expression: Wald test; comparison of similarity between curves: Kolmogorov-
Smirnov test. 
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3.5 Mechanisms of post-transcriptional regulation mediated by Cpeb1 
 
3.5.1 Effect of Cpeb1 knockout on mRNA expression of CPE containing regeneration 
associated genes (RAGs) and RBPs 
 
Taking a deeper look into the RNAseq data, the first question was how do known RAGs 
behave? In particular, we focused on those that contain CPE, in order to infer direct targets of 
Cpeb1 (Fig. 28). Stat3 (Bareyre et al., 2011), Cebpβ (Yan et al., 2009), and Kpnb1 (Perry et 
al., 2012) are pro-regenerative genes that contain CPE. Among them, Cpeb1 knockout 
hindered injury-induced increase of axonal Cebpβ mRNA, suggesting that Cebpβ could be a 
direct target of Cpeb1. Pten and Socs3 are negative regulators of axon regeneration (Liu et 
al., 2010; Sun et al., 2011), both also CPE-containing. The injury-induced decrease of Pten 
mRNA is dampened upon Cpeb1 knockout, agreeing with a previous report showing that 
Pten is a direct target of Cpeb1 (Alexandrov et al., 2012). 
We also looked into Cpeb4, a family member of Cpeb1 which binds to the same motif 
(Charlesworth et al., 2013). It has been reported that Cpeb1 activates the translation of 
Cpeb4, thereafter it replaces Cpeb1 and creates a positive translation loop for CPE-containing 
mRNAs (Igea and Méndez, 2010). Interestingly, Cpeb1 knockout prevents an injury-induced 
decrease in Cpeb4 mRNA, suggesting that Cpeb1 mediates the degradation of Cpeb4 mRNA. 
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Figure 28: Gene expression values for putative Cpeb1 effector genes from RNAseq. ko: Cpeb1 ko. n=3 for wild-
type and n=2 for ko. Error bars: mean +/- S.E.M. 
 
3.5.2 Role of Cpeb1 on RNA stability of putative target mRNAs  
 
As previous data suggests that Cpeb1 regulates the stability of its target mRNAs (Fig. 11, 12, 
28), we directly investigated the stability of its putative targets. Firstly, the mRNA levels of 
putative targets on whole neurons upon Cpeb1 knockout was measured by qPCR, as a 
screening to narrow down the list of candidates. The rationale being that their global levels 
would change if they are targets of Cpeb1-mediated degradation. Genes studied were selected 
from known targets of Cpeb1 from the literature, or from CPE-containing genes that were 
significantly changed upon injury from the TSAA or RNAseq experiments. For all the genes 
that were studied, most have their expression reduced slightly upon Cpeb1 deletion, with 
Stat3 and Kif5c showing the greatest decrease (Fig. 29B).  
To ascertain whether the differences observed are due to degradation, RNA degradation assay 
was performed by treating neurons with actinomycin D, which blocks transcription, and 
tracking the mRNA levels over time. In addition to Stat3 and Kif5c, the assay was also 
performed on Cebpβ, as it is among the most highly up-regulated genes in the total RNA 
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fraction from the TSAA. Surprisingly, deletion of Cpeb1 appears to confer a slightly greater 
stability on the tested genes (Fig. 29C-F).  
 
 
Figure 29: Levels and stability of putative Cpeb1 target mRNAs upon Cpeb1 knockout in whole neurons. A) 
Timeline of experiment setup. B) Relative abundance of candidate mRNAs upon Cpeb1 knockout. C-E) 
Degradation curve of candidate RNAs after actinomycin treatment. F) Calculated mRNA half-lives. ko: Cpeb1 
knockout. RNA levels are measured by qPCR and normalised to Gapdh.  
 
 86 
 
It was suspected that Cpeb1 mediated RNA stability may differ between processes and 
somas, due to different environmental cues; and by analysing RNA from the whole neuron, 
the effect is averaged out. As a result, the degradation assay was repeated on RNAs from 
processes and somas, isolated separately by culturing neurons on transwell chambers. Data 
from the RNAseq shows that Cpeb1 knockout hindered the injury-induced up-regulation of 
many genes in neuronal processes (Fig. 24 and 26). Consequently, attention was turned to 
these genes, in particular c-Jun, Junb, c-Fos, Egr1 and Nfkbia, which show the 
aforementioned behaviour (Fig. 30A-F). qPCR shows that the mRNAs of these genes in both 
processes and somas, with the exception of Nfkbia, are reduced upon Cpeb1 knockout (Fig. 
30G). Interestingly, deletion of Cpeb1 confers little change in mRNA stability in processes 
and somas (Fig. 31). Only a slight reduction in stability was seen for c-Jun in somas and Junb 
in processes. In most cases, a minor increase in stability was observed after knockout. This is 
perhaps not surprising, as RNAseq data shows there are little changes in mRNA abundance 
upon Cpeb1 knockout in naïve processes (Fig. 26). 
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Figure 30: Expression of for putative Cpeb1 target transcription related genes. n=3 for wild-type and n=2 for ko. 
Error bars: mean +/- S.E.M. A-E) Gene expression values from processes from RNAseq. F) Genome tracks 
showing expression. G) Relative abundance of candidate RNAs upon Cpeb1 knockout in processes and somas 
by qPCR. ko: Cpeb1 ko.  
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Figure 31: Stability of putative Cpeb1 target transcription related mRNAs upon Cpeb1 knockout in processes 
and somas. A) Degradation curve of candidate mRNAs after actinomycin treatment and calculated mRNA half-
lives. ko: Cpeb1 knockout. RNA levels are measured by qPCR and normalised to Gapdh. 
 
Accordingly, the experiment was repeated also on injured processes. The panel of targets 
tested was extended to include genes regulating axon regeneration: Klf6 (Moore et al., 2009; 
Veldman et al., 2010) and Zfp36l2 (Cargnin et al., 2014); axon guidance: Noggin (Dionne et 
al., 2002) and Neurod2 (Ince-Dunn et al., 2006); and synaptic development: Ptbp1 (Zheng et 
al., 2012). Zfp36l2 and Ptbp1 are also RBPs and post-transcriptional regulators themselves. 
These candidates all show a hindered injury-induced up-regulation upon Cpeb1 knockout in 
the RNAseq. 
Upon Cpeb1 knockout, Fosb, Klf6 and Zfp36l2 expression was decreased in injured 
processes (Fig. 32). However, RNA degradation assay showed that for the most, Cpeb1 
knockout has little effect stability of the candidate mRNAs (Fig. 33). Although there are 
differences in the calculated half-lives for c-Fos, Fosb, Noggin and Ptbp1, the observation is 
not reliable, as the data points for the degradation curves do not fit well to a straight line.  
Hence, direct targets for Cpeb1-mediated RNA stability requires more extensive screening to 
be identified. One other possibility that explains the increased abundance of mRNAs in 
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injured processes is that CPE mediates the localisation of its host mRNA to the processes 
upon injury. This would require further experiments to elucidate, for example replacing 
actinomycin D treatment with microtubule destabilising chemicals that would inhibit RNA 
transport. Interestingly though, there is a general trend among the tested genes that mRNA 
half lives are increased upon injury, independent of the presence of Cpeb1 (Fig. 33). 
Therefore, it is evident that other factors are also responsible for the up-regulation of these 
genes upon injury, and perhaps these are the direct targets of Cpeb1. 
 
 
Figure 32: Relative abundance of Cpeb1 putative target mRNAs upon Cpeb1 knockout in injured and naïve 
processes. RNA levels are measured by qPCR and normalised to Gapdh. 
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Figure 33: Stability of putative Cpeb1 target mRNAs upon Cpeb1 knockout in injured and naïve processes. A-J) 
Degradation curve of candidate mRNAs after actinomycin treatment. K) Calculated mRNA half-lives. ko: 
Cpeb1 knockout. RNA levels are measured by qPCR and normalised to Gapdh. 
 
3.5.3 Cpeb1 in alternative polyadenylation 
 
It has been reported that Cpeb1 could mediate alternative polyadenylation (APA) of target 
mRNAs (Bava et al., 2013). This process creates transcript variants with different 3’UTRs, 
affecting the presence of cis-acting elements such as RBP and miRNA binding sites and thus 
its post-transcriptional fate. Recently an algorithm called Dynamic analyses of Alternative 
PolyAdenylation from RNA-Seq (DaPars) has been developed that allows genome-wide 
screening of APA events using RNAseq data (Xia et al., 2014). With the help of Mechthild 
Lütge, DaPars was performed to screen for differential APA events using the RNAseq data.  
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It was found that injury and Cpeb1 both influence the usage of 3’UTR isoforms (Fig. 34). In 
the comparison within wild-type samples (Fig. 34C), injury induces a shift towards longer 
3’UTRs and a down-regulation in these genes. This agrees with the general notion that longer 
3’UTRs contain more miRNA binding sites and thus are more readily degraded (Mayr and 
Bartel, 2009).  
 
Figure 34: Differential expression of genes with alternative polyadenylation identified by DaPars. Genes listed 
are identified by DaPars with p<0.05; and with log2FC either >0.75 or <-0.75 and, p<0.05 by Wald’s test. Chi-
square test of distribution: A): p=0.001; B-D) p<0.0001. 
 
Among the genes identified to have differential APA upon Cpeb1 knockout, one is Map2k7, 
an upstream kinase of JNK signalling which in turn activates c-Jun. Map2k7 activates JNK 
signalling, leading to microtubule bundling and elongation of neurites (Yamasaki et al., 
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2011). Map2k7 isoforms possess either a long or a short 3’UTR. The longer 3’UTR causes 
increased localization of the mRNA to neurites, phosphorylation and activation of the 
Map2k7 protein, and elongation of neurites (Feltrin et al., 2012). Importantly, the long 
3’UTR contains 3 CPE motifs whereas the short 3’UTR contains none, and Cpeb1 knockout 
causes a shift to the short 3’UTR in injured processes (Fig. 35A). Therefore, Map2k7 
presents an attractive candidate for investigation, with the hypothesis that Cpeb1 increases 
the usage of the longer 3’UTR of Map2k7 and thus its activation, which in turn increases the 
activation of the JNK pathway, leading to regeneration.  
The ratio of long to short 3’UTR of Map2k7 upon Cpeb1 knockout was thus further 
investigated, by performing qPCR with primers amplifying specifically only one of the 
isoforms. It was found that Cpeb1 knockout causes a shift to the short 3’UTR in whole 
neurons, albeit the difference is not significant (Fig. 35B). In processes the difference is 
minimal, however more replicates are needed to ascertain this. 
 
Figure 35: Effect of Cpeb1 knockout on Map2k7 alternative polyadenylation. A) Genome tracks showing 
expression of Map2k7 3’UTR of wild-type and Cpeb1 knockout injured processes. B) Ratio of long to short 
3’UTR of Map2k7 determined by isoform-specific qPCR. 
 
3.5.4 Polyadenylation status of putative Cpeb1 target mRNAs after neuronal injury 
 
Localised translation in axons is essential towards regeneration (Kalinski et al., 2015; 
Merianda et al., 2015; Verma et al., 2005). This means spatial control over translation is in 
place, with it being repressed initially and only activated when the mRNAs are in their target 
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location. Precise control over mRNA translation occurs via cytoplasmic polyadenylation, a 
process best studied in Xenopus oocytes but also shown in neuronal growth cones (Brittis et 
al., 2002; Lin et al., 2009). Since Cpeb1 is a key regulator of cytoplasmic polyadenylation, 
putative targets of Cpeb1 related to regeneration were studied for their polyadenylation status 
by poly(A) tail (PAT) assays (Fig. 36A). In addition to amplifying the poly(A) tail, an extra 
"UTR" PCR was performed as a control for RNA quality. In the beginning, 3 different 
forward primers were designed for each gene, which were then tested and the best picked for 
subsequent assays. The number of PCR cycles was also tested for a balance between signal 
intensity and accuracy, as the polymerase could slip when amplifying long stretches of the 
same base, and 30 cycles was found to be optimal. 
The PAT assay was first performed on naïve and injured spinal cord tissue for known binding 
targets of Cpeb1: Pten, Cpeb4, and Stat3. However, no difference between naïve and injured 
spinal cords could be observed (Fig. 36B). It was suspected that in spinal cord tissue, RNA 
from other cell types as well as from neuronal cell somas might mask the signal coming from 
the axonal compartment. As a result, the assay was repeated with the length of spinal cord 
taken reduced from 2.5cm to 1cm around the lesion area. However, there was still no 
observable change in poly(A) tail length upon injury (Fig. 36C). Perhaps despite reducing the 
amount of tissue taken, the influence from other cell types and neuronal cell soma is still too 
large.  
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Figure 36: Effect of SCI on polyadenylation. A) Schematics for PAT assay. B) PAT assay with 2.5cm of spinal 
cord tissue around the operated area. C) PAT assay with 1cm of spinal cord tissue around the operated area. N1 
and N2: replicates of naive spinal cord; SCI1 and SCI2: replicates of injured spinal cord; fwd1-3: different 
forward primers priming on the 3'UTR of the same gene; utr: amplified 3’UTR; pA: amplified poly(A) tail. 
 
Consequently, the assay was performed on RNAs isolated from processes or cell somas from 
embryonic cortical neurons by culturing them on transwell chambers (Fig. 37). Injury 
induced an increase in poly(A) tail length for Kpnb1, agreeing with the fact that localized 
translation of Kpnb1 in axons is a part of injury induced response (Perry et al., 2012). On the 
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other hand, a shortening of poly(A) tail for Cpeb4 was observed. Knockout of Cpeb1 
increases the poly(A) tail length for Cpeb4 and β-catenin in injured processes, suggesting that 
Cpeb1 shortens the poly(A) tails of these two mRNAs upon injury. 
 
Figure 37: Effect of injury and Cpeb1 knockout on polyadenylation. A) Timeline for experimental setup. B and 
C) PAT assay on cell somas and somas of wild-type and Cpeb1 knockout neurons. Red asterisk: difference 
between injured and naïve; yellow triangle: difference between Cpeb1 knockout and wild-type. utr: amplified 
3’UTR; pA: amplified poly(A) tail. 
 
3.5.5 Role of polyadenylation on axonal regeneration 
 
To investigate if regeneration mediated by localised translation occurs via polyadenylation, 
the effect on axonal regrowth by inhibiting polyadenylation with cordycepin was studied. To 
allow axon specific treatment, cortical neurons were cultured in axis isolation devices 
(AXISs) (Park et al., 2006). Microfluidic pressure forces axons to develop through narrow 
channels that block cell somas (Fig. 38B). Axotomy was performed by applying vacuum to 
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the axonal compartment to suck away the medium together with the axons. The compartment 
was then refilled with medium containing the corresponding inhibitor, and regrowth was 
quantified 14 hours later. However no significant differences in terms of either number or 
length of regenerated axons was observed (Fig. 38C and D). Inhibition of translation with 
cycloheximide causes a small but insignificant decrease in these parameters. Culturing 
neurons within tight environment of the chamber caused bad viability and high variability, 
possibility the reason causing the lack of reliable observations. 
 
Figure 38: Effect of axonal inhibition of polyadenylation and translation on regrowth. A) Timeline for 
experimental setup. B) Schematics and representative picture showing the working of an AXIS device. B and C) 
Number and median length of regenerated axons.  cor: cordycepin treated; chx: cycloheximide treated. n=7 for 
control, n=4 for cordycepin and cycloheximide. Error bars: Mean +/- S.E.M. Statistical test: Mann-Whitney. 
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3.5.6 Mediators of Cpeb1 regulated injury response 
 
Since most injury-induced changes in mRNA abundance in neuronal processes were found to 
be unrelated to CPE (Fig. 25 and 27), it was postulated that much of the response comes from 
indirect targets of Cpeb1. To investigate through which molecules this is mediated, which 
will give an idea on what could be the direct targets of Cpeb1, Upstream Regulator Analysis 
from Ingenuity was performed. This predicts the upstream regulators based on the provided 
expression data. Two lists were analysed: genes exclusively regulated in wild-type and not 
Cpeb1 knockout processes upon injury (Table 7) and genes regulated in Cpeb1 knockout 
versus wild-type in injured processes (Table 8). The analysis does not predict Cpeb1 as an 
upstream regulator, but manual inspection of the database revealed there are very few 
annotated targets of Cpeb1, making prediction of Cpeb1 unlikely. 
Within the first list, a number of transcription regulators were predicted to be both activated 
and repressed upstream regulators, reflecting the increased gene expression changes in wild-
type compared to Cpeb1 knockout processes (Table 7). Among them, Crem and Myc have 
increased expression upon injury in the RNAseq data. These two genes also possess CPEs in 
at least in some of their isoforms, thus suggesting they may be direct targets of Cpeb1-
mediated RNA stability. In particular, Crem, which is a part of the cAMP-mediated signal 
transduction and binds the cAMP responsive element (CRE) in promoters of many genes, is 
predicted to be repressed in the injured processes upon Cpeb1 knockout (Table 8). Crem 
possesses a large number of transcript isoforms which translates into both activators and 
repressors of transcription (Behr, 2000; Foulkes et al., 1992), thus it could also be a target for 
Cpeb1-mediated alternative splicing or polyadenylation. Targets of Crem found to be up-
regulated include Btg2 and Cebpb, both enhancers of axonal growth (Miyata et al., 2008; Yan 
et al., 2009) (Fig. 39). For the other transcription factors predicted to be activated upstream 
regulators, there is no significant change in mRNA levels in the RNAseq. However, this does 
not rule out that they are not regulated by Cpeb1 via polyadenylation and translation. 
Interestingly, a number of growth factors and the pro-regeneration cytokine IL6 are predicted 
to be activated upstream regulators (Table 7). This likely reflects only the fact that a 
repertoire of growth-related genes was up-regulated, as neurons are not known to produce 
growth factors or cytokines themselves. This is confirmed by checking the genome tracks of 
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these growth factors. In addition, the mRNA levels of these predicted growth factors are not 
significantly different upon injury. 
Upstream 
Regulator 
log2FC in 
dataset 
Molecule Type 
Predicted 
Activation 
State 
Activation 
z-score 
p-value of 
overlap 
IL6 
 
cytokine Activated 2.779 4.36E-04 
MAP2K1/2 
 
group Activated 2.177 6.64E-03 
Jnk 
 
group Activated 2.187 7.13E-02 
Vegf 
 
group Activated 3.613 5.80E-03 
Akt 
 
group Activated 2.011 1.54E-01 
ERK 
 
group Activated 2.088 3.73E-04 
NGF 
 
growth factor Activated 2.009 1.53E-08 
BMP4 
 
growth factor Activated 2.026 2.64E-02 
FGF1 
 
growth factor Activated 2.095 4.70E-05 
FGF10 
 
growth factor Activated 2.2 1.25E-02 
FGF2 
 
growth factor Activated 3.13 3.08E-09 
TGFB1 
 
growth factor Activated 2.696 1.27E-13 
EGF 
 
growth factor Activated 3.19 2.38E-07 
IKBKG 
 
kinase Activated 2.373 1.03E-01 
CREM 1.779 
transcription 
regulator 
Activated 2.181 3.81E-07 
GLI1 
 
transcription 
regulator 
Activated 2.123 1.80E-05 
CREB1 
 
transcription 
regulator 
Activated 5.328 5.47E-21 
YBX1 
 
transcription 
regulator 
Activated 2 1.35E-02 
SMAD4 
 
transcription 
regulator 
Activated 2.182 1.06E-02 
MYCN 
 
transcription 
regulator 
Activated 2.639 7.70E-09 
TP53 
 
transcription 
regulator 
Activated 2.642 1.88E-22 
MYC 1.092 
transcription 
regulator 
Activated 2.418 5.12E-15 
EIF4E 
 
translation 
regulator 
Activated 2.21 1.01E-03 
DICER1 
 
enzyme Inhibited -2.375 8.71E-05 
MIR124 
 
group Inhibited -2 7.53E-03 
BDNF 
 
growth factor Inhibited -3.043 2.07E-17 
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miR-155-5p 
(miRNAs 
w/seed 
UAAUGCU) 
 
mature microrna Inhibited -2.425 7.04E-04 
miR-34a-5p 
(and other 
miRNAs 
w/seed 
GGCAGUG) 
 
mature microrna Inhibited -2.605 4.01E-04 
miR-124-3p 
(and other 
miRNAs 
w/seed 
AAGGCAC) 
 
mature microrna Inhibited -4.2 3.24E-05 
mir-155 
 
microrna Inhibited -2.177 6.22E-02 
let-7 
 
microrna Inhibited -3.504 6.34E-05 
mir-122 
 
microrna Inhibited -2.538 1.05E-04 
mir-22 
 
microrna Inhibited -2.2 6.17E-04 
SOX1 
 
transcription 
regulator 
Inhibited -2.236 4.31E-02 
SOX3 
 
transcription 
regulator 
Inhibited -2.236 1.68E-02 
Table 7: Predicted upstream regulators in genes exclusively regulated in wild-type and not in Cpeb1 knockout 
processes upon injury. 
  
 100 
 
 
Upstream 
Regulator 
log2FC in 
dataset 
Molecule Type 
Predicted 
Activation 
State 
Activation 
z-score 
p-value of 
overlap 
STAT4 
 
transcription 
regulator 
Inhibited -2,216 1,57E-01 
CREM 
 
transcription 
regulator 
Inhibited -2,219 1,29E-02 
CREB1 
 
transcription 
regulator 
Inhibited -3,192 6,88E-05 
MYCN 
 
transcription 
regulator 
Inhibited -2,425 9,90E-02 
IL1B 
 
cytokine Inhibited -2,309 3,08E-01 
HOXA10 
 
transcription 
regulator 
Activated 2,000 2,04E-01 
miR-125b-5p 
(and other 
miRNAs w/seed 
CCCUGAG) 
 
mature microrna Activated 2,193 6,36E-03 
Table 8: Predicted upstream regulators in injured processes upon Cpeb1 knockout. 
 
 
Figure 39: Network of genes regulated by Crem in A) genes exclusively regulated in wild-type and not in Cpeb1 
knockout processes upon injury and B) injured processes upon Cpeb1 knockout  
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4. Discussion 
 
4.1 Widespread uncoupling between transcription and translation in 
axonal regeneration and its functional relevance 
 
Neurons are highly polarized cells with axons stretching up to several metres, thus the tip of 
an axon could be far removed from the cell soma. In such conditions, post-transcriptional 
regulation in the axoplasm provides a way for better spatial and temporal control over for 
protein expression (Holt and Schuman, 2013; Jung et al., 2012). This includes regulation of 
mRNA stability, transport of mRNAs to their target locations, translation silencing and 
activation, and protein degradation. Several studies have already demonstrated the relevance 
of localized translation in injured axons (Hanz et al., 2003; Perry et al., 2012; Yan et al., 
2009). While these studies point to the behaviour of individual candidate genes, others have 
revealed that this phenomenon is widespread. For example, it has been discovered that the 
axonal repertoire of mRNAs changes substantially in response to injury in cortical neuron 
cultures (Taylor et al., 2009). In DRG neurons, injury-conditioned axons have increased 
levels of ribosomal protein P0 and phosphorylated eIF4E than non-conditioned ones (Verma 
et al., 2005). Mirroring these findings, growth cone-associated mRNAs Actb, Gap43 and 
Nrn1 have increased abundance in regenerating sciatic axons than in naïve ones, and the 
same goes for ribosomal components S6 and 5.8S rRNA and activated forms of the 
translation factors eIF2α and 4EBP (Kalinski et al., 2015). Findings from the simultaneous 
profiling of mRNA abundance and ribosome loading in the current study are in line with this 
notion, revealing extensive uncoupling between transcription and translation in the injured 
spinal cord (Fig. 8). Confirming that regenerating axons do have increased levels of protein 
synthesis, conditioned DRG axons have increased incorporation of radioactively labelled 
amino acids, and selective treatment of axons with cycloheximide severely hinders 
regeneration  (Verma et al., 2005). Interestingly, the levels of ribosome components, 
translation factors and growth cone-associated mRNAs in transected spinal cord axons 
regenerating through a peripheral nerve graft are comparable to those of regenerating sciatic 
axons, suggesting that the capability to regenerate might be determined by the ability to 
synthesize certain mRNAs in the axon (Kalinski et al., 2015). Additionally, deletion of Pten, 
a negative regulator of mTOR signalling and protein synthesis, enhances axon regeneration in 
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RGCs (Park et al., 2008). Interestingly, in our data, although the time point taken for 
performing the spinal cord microarray is within the regenerative phase after SCI (Cajal, 1928; 
Kerschensteiner et al., 2005), a general decrease in ribosomal loading is observed (Fig. 8). 
On closer inspection by GO functional clustering of differentially regulated genes in total and 
polysome-bound RNA fractions, it was found that CNS development genes have reduced 
mRNA abundance after SCI, being some of the most under-enriched GO categories. On the 
other hand, their ribosomal loading remained similar (Fig. 9). Down-regulation of mRNAs of 
neuron development genes could also be seen in injured cortical neurons (Fig. 24E). This 
suggests that although CNS development genes have their numbers of transcripts decreased 
after SCI, the remainder are translated more efficiently, possibly supporting the transient 
regeneration. We thus hypothesise that at this transient regenerative phase, axonal growth 
comes from translation of pre-existing pro-regeneration mRNAs, and is forced to stop when 
these mRNAs reach the end of their lifespan and are not replaced. 
This is supported by the outgrowth screening in Drosophila, which shows that a considerable 
number of uncoupled genes that are effectors of axonal outgrowth show uncoupled behaviour 
after SCI, with reduced mRNA abundance but similar ribosomal loading (Fig. 21, Table 6). 
The neuron-specific aspect of the screening is important, as it shows that these genes are part 
of the intrinsic neuronal regenerative programme.  
The use of the uncoupled response as a screening criterion in searching for factors 
influencing axonal growth also proved to be more efficient than based on prior knowledge on 
their role in neural and neurite development (Bassem Hassan, personal communication), 
indicating that genes governing regeneration are often subject to a tight post-transcriptional 
regulation. Interestingly, overexpression of these mRNAs was enough to increase axon 
outgrowth, hinting that the regulation comes from RNA degradation. 
 
4.2 Increase in mRNA abundance of Jun and Fos family of transcription 
factors upon injury 
 
If regulation of RNA degradation is the main mechanism governing the capability for 
regeneration, then it could be delineated by analyzing the transcriptome alone. In analyzing 
 103 
 
the repertoire of mRNAs in naïve and injured wild-type neuronal processes using RNAseq, 
neuron-specific responses to injury could be elucidated, and with a much higher resolution 
than by microarray analysis. With that it was discovered that there is an up-regulation of 
mRNAs for the Jun and Fos family of transcription factors (Fig. 30).   
The AP-1 transcription factor consists of a variety of dimers formed by different 
combinations of proteins from the Jun and Fos families. Members of the Jun and Fos families 
are considered to be early response genes that are expressed rapidly following axotomy as 
well as a number of other cellular insults (Herdegen et al., 1997; Leah et al., 1991). 
Specifically, c-Jun and c-Fos mRNAs were up-regulated within hours after lesion of sciatic 
nerve, subsequently inducing expression of nerve growth factor (NGF) (Hengerer et al., 
1990). In line with this, c-Jun, Junb, c-Fos and Fosb were all highly up-regulated upon 
axotomy in wild-type axons. Most interestingly, this increase is much attenuated in Cpeb1 
KO axons (Fig. 30), strongly suggesting the involvement of Cpeb1 in their expression 
regulation. In addition, these genes all contain CPEs in their transcripts. In particular, Cpeb1 
has been shown to bind to the 3’UTR of c-Jun mRNA, and Cpeb1 knockout reduces c-Jun 
protein levels and subsequent activation of c-Jun target genes (Zearfoss et al., 2008). 
There is strong evidence linking c-Jun to axonal injury response, with its expression 
persisting long after axon damage (Jenkins and Hunt, 1991). In addition, c-Jun expression is 
associated with the intensity of cell body reaction to injury. For example, rat rubrospinal 
neurons proximally axotomised by a C3 spinal cord transection, which elicits cell death and 
regeneration responses, expresses c-Jun robustly. On the other hand, those that were distally 
axotomised by a T10 spinal cord transection, which induces little reaction in the cell body, 
have minimal c-Jun expression (Jenkins et al., 1993; Richardson and Issa, 1984). The same 
association was observed upon transection of optic nerve (Hüll and Bähr, 1994; Robinson, 
1995). The pro-regenerative effect of c-Jun has been demonstrated in many studies. Strong c-
Jun expression correlated with regeneration of RGC axons through a peripheral nerve graft 
(Robinson, 1995). In another study, using axotomy of rat facial nerve as a model, deletion of 
c-Jun inhibited target muscle reinnervation, but rendered the motor neurons resistant to 
axotomy-induced cell death (Raivich et al., 2004). On the other hand, c-Jun is also associated 
with neuronal cell death, when neutralization of c-Jun protects sympathetic neurons against 
cell death induced by NGF withdrawal  and overexpression of wild-type c-Jun induces 
apoptosis (Estus et al., 1994; Ham et al., 1995). The apparent ambivalent function of c-Jun 
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has been proposed to be a result of context-dependent interaction with other AP-1 proteins. 
Junb, c-Fos and Fosb show fluctuating or no increased expression following sciatic nerve 
crush injury, in contrast to c-Jun which showed prolonged increased expression for more than 
2 months (Herdegen et al., 1992; Molander et al., 1992). In addition, purification of AP-1 
consensus sequence binding proteins from axotomised and regenerating DRG neurons 
contains c-Jun but not c-Fos (De León et al., 1995). These data suggest a role for c-Jun in a 
signalling crossroad downstream of JNK following axonal injury, with the response 
determined in conjunction with other AP-1 factors such as c-Fos and ATF2 (Herdegen et al., 
1997). 
 
4.3 Association of RBPs with changes in mRNA abundance upon injury to 
spinal cords and cortical neurons 
 
4.3.1 Cpeb1 influences changes in mRNA abundance in injured spinal cords and 
cortical neurons  
 
Through this study, it was confirmed that CPE is a modulator of transcript behaviour in SCI. 
It is surprising that the influence is in the total and not the polysome-bound RNA fraction 
(Fig. 11), as Cpeb1 is a well known regulator of cytoplasmic polyadenylation. However, 
various groups have demonstrated that Cpeb1 has additional functions, such as RNA 
transport and storage. Cpeb1 transports its target mRNAs into dendrites in ribonucleoprotein 
(RNP) in rat hippocampal neurons, in a microtubule-dependent manner (Huang et al., 2003). 
Map2 is one of such targets, and overexpression of Cpeb1 increases dendritic localization of 
Map2 mRNA (Huang et al., 2003). Also, Cpeb1 has been found to be a component of stress 
granules and dcp1 bodies, which are involved in mRNA storage and degradation (Wilczynska 
et al., 2005). Overexpression of Cpeb1 increases the assembly of these structures, and this 
process is dependent on its RNA binding domain but not the phosphorylation site used by the 
kinase Aurora A to activate Cpeb1 for polyadenylation (Wilczynska et al., 2005). Similarly, 
deletion of the phosphorylation site does not alter the distribution of Cpeb1-containing foci 
within dendrites and synapses of Xenopus optic tectal neurons, suggesting that the function of 
Cpeb1 to transport and target mRNAs to RNP complexes is independent of its role in 
 105 
 
polyadenylation (Bestman and Cline, 2009). Foci of inactive mutant Cpeb1 located near 
synapses do, however, show higher intensities than those of wild-type Cpeb1, suggesting that 
inability to activate translation may trap Cpeb1 and its target mRNA within the RNP complex 
(Bestman and Cline, 2009). A possible scenario linking these observations is that inactive 
Cpeb1 assembles its binding mRNA into RNP complexes, simultaneously repressing its 
translation and protecting it from degradation, while guiding it to its final location. This 
would agree with the observation that CPE-containing mRNAs are less decreased following 
SCI (Fig. 11A). Cpeb1 could preserve the transcripts and allow rapid reinitiation of 
translation at later time points. Further details related to Cpeb1 regulation of RNA 
degradation and transport are discussed in the following sections. 
In the RNAseq of neuronal processes, another phenomenon was observed. Knockout of 
Cpeb1 has a large attenuating effect on the amplitude of the transcriptional injury response, 
with wild-type processes exhibiting a much larger fold change and in more genes than in 
Cpeb1 knockout ones (Fig. 24B and C). However, we did not observe an enrichment of the 
CPE motif among the differentially regulated mRNAs (Fig. 25A and B). One likely reason is 
that the time point chosen (24 hours post injury) is late, and by then the gene expression 
response is already dominated by late response genes and indirect downstream targets of 
CPE-containing transcripts. It would therefore be useful to repeat the experiment at earlier 
time points to investigate whether the CPE motif is enriched in upstream regulators of the 
injury response. Although earlier time points might not be easily feasible, as with less time 
after injury, the processes would have undergone less regrowth, which further reduces the 
already limited amount of collected RNA. 
In silico upstream analysis has identified Crem to be a regulator of the injury response, which 
changes in wild-type processes upon injury but not in their CPEB1-deficient counterparts 
(Table 7 and Fig. 39). Crem transcripts increase upon injury, and at least some of its isoforms 
contain CPE. Crem is a part of the cAMP-mediated signal transduction and binds the cAMP 
responsive element (CRE) in promoters. Together with the closely related CRE binding 
proteins (Creb), it mediates response to many neurotrophin signalling pathways (Lonze and 
Ginty, 2002) and confers protective effects against neuronal cell death in the CNS in 
homeostasis and after injury (Mantamadiotis et al., 2002; Wu et al., 2012) and promotes axon 
outgrowth both in vivo and in vitro (Lonze et al., 2002). Crem possesses a large number of 
transcript isoforms that translates into both activators and repressors of transcription, 
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contributing to spatial and temporal regulation of gene expression (Lonze and Ginty, 2002). 
Although the repressor forms are driven from a 3’ intronic promoter, leading to a truncated 5’ 
end which separates them form the activator forms, the different forms also differ in their 
3’UTRs (Sassone-Corsi, 1998). It is thus possible that Cpeb1 could exert its control based on 
different possession and arrangement of CPEs on the activator and repressor forms of Crem. 
Targets of Crem found to be up-regulated in our dataset include Btg2 and Cebpb, both of 
them being enhancers of axonal growth (Miyata et al., 2008; Yan et al., 2009) (Fig. 34). 
On scrutinizing by further sub-dividing differentially regulated mRNAs in the RNAseq 
according to the number of CPEs they possess, a general association could be observed where 
the proportion of down-regulated transcripts decrease with increasing number of CPEs, 
whereas the up-regulated ones remains similar (Fig. 25C). This hints at some form of additive 
effect or interplay between the CPEs. CPE can exist in multiple copies in the 3’UTR of the 
same transcript, although there are less transcripts possessing higher number of CPEs (Fig. 
25C), probably due to limitation from the length of the 3’UTR.  
Indeed, it has been shown that the number of CPEs affects the way that Cpeb1 regulates RNA 
dynamics. In Xenopus meiotic progression, mRNAs of “early” genes, such as Mos and cyclin 
A1, have only one CPE, and they are polyadenylated once Cpeb1 is activated by 
phosphorylation. On the other hand, “late” genes such as cyclin B1 have more than one CPE. 
Dimerisation of the multiple Cpeb1 bound to these mRNAs precludes their interaction with 
CPSF, and prevents immediate polyadenylation. Subsequent degradation of Cpeb1 mediated 
by the meiotic programme reduces the Cpeb1:CPE ratio, rendering some of the CPEs empty, 
allowing the remaining Cpeb1 to interact with CPSF and induce polyadenylation in “late” 
genes (Méndez et al., 2002). This phenomenon has been discovered later also to occur in 
mammalian cell cycle progression, with destruction of Cpeb1 mediated by the isomerase Pin1 
via ubiquitination (Nechama et al., 2012). This complex step-wise activation allows a single 
master regulator to control the fate of multiple target mRNAs, even if they are to be 
translated at different times. In addition, CPE interacts with other cis-acting elements, namely 
PBE and Hex, and the number, arrangement and distance between these elements on the 
3’UTR forms a combinatorial code that will determine the polyadenylation outcome of the 
mRNAs harbouring them (Piqué et al., 2008). Although the aforementioned studies are 
concerned with polyadenylation and translation, nevertheless it illustrates the complex 
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regulation by Cpeb1 and other cis-acting elements on the 3’UTR, implying that perhaps the 
same is true for regulation of RNA stability. 
 
4.3.2 AREs increase mRNA abundance in injured spinal cords 
 
While the direct effect Cpeb1 exerts on its target mRNA upon neuronal injury would require 
more work to be elucidated, a link was found between CPE and AREs. Most transcripts 
containing CPE also possess AREs, and transcripts containing both motifs have higher 
mRNA abundance and ribosomal loading than those that do not after SCI (Fig. 14D). ARE 
promotes RNA stability when bound by the HuR family of proteins (Peng et al., 1998; 
Schoenberg and Maquat, 2012). In particular, the neuron specific HuD increases the half-life 
of the pro-regenerative mRNA Gap43 (Beckel-Mitchener et al., 2002; Mobarak et al., 2000) 
and is crucial to its localization to axons, where Gap43 induces axon elongation (Yoo et al., 
2013). In a study using superior cervical ganglion axons, the mRNA levels of 
acetylcholinesterase (AChE), an enzyme responsible for neurotransmission that also plays a 
role in neurite elongation (Koenigsberger et al., 1997), is reduced following axotomy 
(Deschênes-Furry et al., 2007). This was induced by a decrease in mRNA stability, and 
coincides with a reduction of HuD binding to the ARE region found on the 3’UTR of AChE 
mRNA. Exogenous expression of HuD was found to maintain the mRNA levels of AChE as 
well as Gap43 after SCG axotomy (Deschênes-Furry et al., 2007). Hence, Cpeb1 might work 
together with HuD in protecting target mRNAs from degradation and enhance axon regrowth 
upon axonal injury.  
On polyadenylation, ARE was found to act opposite to CPE, promoting deadenylation by 
recruiting the CCR4 deadenylase to the mRNA. This delays polyadenylation of these mRNAs 
to a “third” wave (after the “early” and “late” genes mentioned previously), which occurs 
during interkinesis in Xenopus oocyte meiosis (Belloc and Méndez, 2008). However, within 
our TSAA, no association was observed on ribosome-loading with the possession of both 
CPE and ARE (Fig. 14D). 
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4.4 Regulation of RNA metabolism on axon growth and regeneration and 
the involvement of Cpeb1 
 
4.4.1 RNA degradation, transport and the role of miRNA and RNPs 
 
One intriguing point coming from this study is that upon the tested target genes, Cpeb1 does 
not seem to impart any influence on mRNA stability (Fig. 29, 31, 33), but the stability of 
most targets were increased upon injury (Fig. 33). Therefore there appears to be separate 
mechanisms in play increasing the stability of RNAs upon injury. 
The miRNA pathway, being a common regulator of RNA dynamics, is naturally a prime 
target for investigation. Indeed, there is extensive differential regulation of miRNAs upon 
injury to DRG and the spinal cord (Liu et al., 1997; Zhou et al., 2012). Some identified 
miRNAs had a transient up-regulation within a few hours after SCI followed by long term 
down-regulation, indicating the temporal control of gene expression in different phases 
following SCI (Liu et al., 2009). Another study reported that the repertoire of axonal 
miRNAs changes substantially upon injury to the sciatic nerve. Predicted targets of these 
miRNAs are related to microtubule dynamics, neurite outgrowth, and degeneration of spinal 
cord, indicating there is an important functional role played by miRNAs in injury response 
(Phay et al., 2015). Protein mediators of RNAi such as Ago3, Ago4 and Dicer were also 
found to localise to DRG growth cones and distal axons (Hengst et al., 2006). Selective 
application of siRNA against RhoA in distal axons reduces RhoA mRNA levels only in distal 
axons and prevented Sema3A-induced growth cone collapse, demonstrating the functionality 
of the axonal RNAi machinery (Hengst et al., 2006). Among the miRNAs that are down-
regulated upon SCI, many are predicted to target apoptosis related genes such as caspase-3 
and Bcl2 (Liu et al., 2009). The loosening of repression on anti-apoptosis genes agrees with 
the observation in our data, that they are up-regulated after injury (Fig. 24). In addition, miR-
222, which is differentially regulated upon injury in DRG neurons, directly targets Pten 
mRNA and increases neurite outgrowth in DRG neurons (Zhou et al., 2012). Interestingly, 
microRNAs are involved in activities of Cpeb1. Cpeb1 and its activating kinase Aurora A are 
targeted by miR-122 and let-7 respectively (Burns et al., 2011; Schnepp et al., 2015).  
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miRNA-directed RNA silencing was shown to have a heavy connection to p-bodies and other 
RNPs, which are RNA-protein complexes for storage and degradation of RNAs. Many 
proteins associated with RNA-induced silencing complex (RISC) were found in p-bodies, 
including the argonaute proteins (Kulkarni et al., 2010). In addition, the decapping enzyme 
Dcp1 and the 5’ to 3’ riboexonuclease Xrn1p, both components of p-bodies, as well as Ago2 
and Upf1 (mediators of nonsense mediated decay), are concentrated in Staufen- and FMRP-
containing RNPs in Drosophila CNS neuron cultures, linking miRNA and p-bodies to these 
RNPs in a neuronal context (Barbee et al., 2006). These RNPs do appear to be associated to 
injury response, as expression of FMRP, Ago2 and Dcp1 are induced upon injury to sciatic 
nerve and DRG neurons, and Dcp1 localisation to DRG axons increases after a conditioning 
injury (Wu et al., 2011).  
Of particular note, LSm1, another factor for RNA degradation, forms RNPs together with 
Dcp1 and Xrn1p (Ingelfinger et al., 2002), and transports RNAs such as β-actin, Map1b and 
eEF1α to dendrites, with stimulation of glutamatergic receptors inducing localisation of 
LSm1 into dendritic spines of cultured hippocampal neurons (di Penta et al., 2009). The fact 
that these RNPs contains RNA degradation enzymes but also transports mRNAs suggests that 
the transport and degradation of mRNAs are tightly connected. LSm1 RNPs also contains 
CBP80, a cap binding protein that associates with pre-mRNAs, indicating that the complex is 
formed inside the nucleus (di Penta et al., 2009). 
Interestingly, Cpeb1 is also found within the LSm1 containing p-bodies in the hippocampus 
(di Penta et al., 2009) and in p-bodies as well as stress granules in HeLa cells (Wilczynska et 
al., 2005), which are structures for RNA storage during cell stress. It is thus speculated that 
Cpeb1 could shuffle its target RNAs into p-bodies, which then undergo transport or 
degradation. Supporting this notion, Cpeb1 mutants lacking its RRM is unable to be 
incorporated into p-bodies and stress granules (Wilczynska et al., 2005). In addition, stress 
granules induced by Cpeb1 overexpression but not by arsenite treatment, was shown to 
recruit components of p-bodies, and it was proposed that Cpeb1 is responsible for linking 
stress granules and p-bodies, shuffling RNAs stored in stress granules down the path to 
degradation by p-bodies (Wilczynska et al., 2005). 
Within our data, Cpeb1 knockout induces a change in axonal levels of a number of CPE 
containing mRNAs upon injury (Fig. 32). However the lack of association between Cpeb1 
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and the stability of tested CPE containing mRNAs (Fig. 33) suggests that Cpeb1 probably 
plays a bigger role in the transport rather than the degradation or RNA storage aspect of 
RNPs. Indeed, Cpeb1 do serves a role in neuronal mRNA transport. Cpeb1 is able to 
transport mRNAs of Bdnf, CamKII and Map2 into dendrites of hippocampal neurons (Huang 
et al., 2003; Oe and Yoneda, 2010). It was demonstrated that CPE alone is sufficient to target 
mRNA to dendrites, when Gfp reporter with a polylinker containing a triplicate CPE has 
increased transport into dendrites over one without CPE (Huang et al., 2003). Cpeb1 RNPs 
contain the motor proteins dynein and kinesin, and a Cpeb1 mutant that could not interact 
with these motor proteins causes hindered transport of Map2 mRNA. Proving that the 
transport mechanism is dependent on microtubules, dendritic localisation of Cpeb1 particles 
is abolished when the microtubule is disrupted by vincristine treatment (Huang et al., 2003). 
In addition, activity-dependent transport of Bdnf mRNA into hippocampal neuron dendrites 
is Cpeb1 dependent, with depolarisation enhancing the binding of Cpeb1 to the 3’UTR (Oe 
and Yoneda, 2010), demonstrating it is part of the temporal control of localised gene 
expression. 
Together, these findings points to the direction that Cpeb1 organises its target mRNAs into 
RNPs for degradation or storage and transport. One important point that remains unclear, is 
whether this is mediated actively by Cpeb1 itself via modifications or dimerisation  of the 
Cpeb1 protein; or if Cpeb1 is bound to these RNAs merely due to its role in repressing 
translation, and the fate of the repressed mRNAs are decided by other factors.  
 
4.4.2 Alternative polyadenylation 
 
Among the many means to regulate protein expression, alternative polyadenylation (APA) is 
one of them. APA determines where polyadenylation begins in the 3’UTR, thus generating 
heterogeneous 3’UTRs, similar to what alternative splicing does to coding exons 
(Di Giammartino et al., 2011). This affects the presence of motifs on the 3’UTR such as 
binding motifs for RBPs and miRNAs, and may have an effect on the stability, intracellular 
localization and translation of the transcript.  
Polyadenylation signals consists of the canonical AAUAAA and AUUAAA sequences, but 
10 single base variants have been discovered (Beaudoing, 2000). Up to 54% and 32% of 
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genes were found to contain multiple polyadenylation sites for their transcripts in the human 
and mouse genomes respectively (Tian et al., 2005). Within transcripts containing multiple 
polyadenylation sites, the 3’-most site tends to use canonical signals and the 5’ sites tend to 
use variant signals, suggesting that proximal sites are used less efficiently and requires 
auxiliary factors (Beaudoing, 2000). A shorter 3’UTR leads to higher mRNA stability and 
protein expression, due to loss of miRNA binding sites and other cis regulatory elements 
(Mayr and Bartel, 2009). APA has been found to affect ubiquitiously transcribed genes 
during transformation and differentiation and creates different 3’UTR ratios, with genes 
involved in tissue-specific processes having their shorter 3’UTR isoforms being 
predominantly expressed (Lianoglou et al., 2013). APA was found to feature extensively in 
cancer cells where the mRNA isoforms of shorter 3’UTR is preferentially expressed (Mayr 
and Bartel, 2009). The shorter isoforms of the proto-oncogene IGF2BP1/IMP-1 has a higher 
transformation potential than the full length mRNA, leading to the hypothesis that APA is the 
reason that oncogenes are overexpressed in some cases where there is no genetic alteration 
(Mayr and Bartel, 2009). 
In our data, with the DaPars algorithm, genes were analyzed for the occurrence of APA. In 
wild-type processes, a considerable number of genes underwent 3’UTR lengthening upon 
injury, with the corresponding expected down-regulation in expression, likely due to the 
presence of more miRNA binding sites in the longer 3’UTR (Fig. 34C). However this 
expected correlation between 3’UTR lengthening and expression is not observed for other 
comparisons. Regardless, APA events were also detected in naïve and injured processes upon 
Cpeb1 knockout (Fig. 34A and B), suggesting a role for Cpeb1. Indeed, of the many 
functions discovered for Cpeb1, regulation of APA is one of them. Cpeb1 was found to 
shuttle into the nucleus and recruit splicing factors to different polyadenylation sites and 
mediates the 3’UTR shortening of a cohort of transcripts, and this  correlates with increased 
cell proliferation and tumourigenesis in tumour cells (Bava et al., 2013). In our dataset, 
Map2k7 is among the genes identified by DaPars to have undergone APA upon Cpeb1 
knockout. Map2k7 poses as an interesting target, as Map2k7 promotes elongation of neurites 
via organisation of microtubules (Yamasaki et al., 2011), and is thus a candidate gene for 
Cpeb1 to promote regeneration via activation of the JNK pathway in our system. Importantly, 
the long 3’UTR isoform increases the effectiveness of Map2k7, by increasing localisation to 
neurites and enhances phosphorylation and activation of the protein. Importantly, Cpeb1 
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knockout shifts the bias towards the short 3’UTR in our data (Fig. 35A), and the long 3’UTR 
contains CPEs whereas the short one contains none. This highly suggests that Cpeb1 
promotes usage of the longer 3’UTR via binding to CPEs. On validation, the long to short 
3’UTR ratio is indeed lower upon Cpeb1 knockout, but only in whole neuron samples (Fig. 
35B). Perhaps the amount of RNA extracted from processes is too low, reducing sensitivity. 
A good alternative experiment would be to transfect cells with a reporter mRNA like Gfp 
fused to the 3’UTR of Map2k7, and check for differences in APA events as well as reporter 
expression and localisation upon Cpeb1 knockout or overexpression. 
 
4.4.3 Polyadenylation and translation 
 
Localised translation in axonal regeneration has been demonstrated in various studies 
(Kalinski et al., 2015; Verma et al., 2005). Interestingly, in one study, inhibition of translation 
by systemic treatment with cycloheximide immediately after SCI reduced neuronal apoptosis 
and  long term functional recovery (Liu et al., 1997), though perhaps this is mediated via 
reduction in inflammation as the  aforementioned treatment is not neuron specific. As 
cytoplasmic polyadenylation is a precursor to reactivation of translation of repressed mRNAs, 
it is thought that this is perhaps the way through which regulation of translation in SCI is 
executed. Indeed, in a neuronal context, blocking polyadenylation reduces growth cone 
collapse in response to Sema3A treatment in Xenopus retinal axons (Lin et al., 2009). In 
addition, Cpeb1 mediates dendrite morphogenesis of hippocampal neurons via cytoplasmic 
polyadenylation of NDUFV2, a component of the electron transport chain complex I 
(Oruganty-Das et al., 2012). Knockout of Cpeb1 reduces translation of Ndufv2, activity of 
electron transport chain complex I and cellular ATP levels, ultimately decreasing dendrite 
length and branching in the dentate gyrus (Oruganty-Das et al., 2012). However, we were 
able to detect little definitive changes in poly(A) tail lengths upon Cpeb1 knockout among 
our tested targets (Fig. 37). This could be attributed to the complex regulation of 
polyadenylation, with the number and arrangement of CPE and other RBP binding motifs all 
exerting an influence on the timing and sequence of  polyadenylation events (Méndez et al., 
2002; Nechama et al., 2012; Piqué et al., 2008). 
 113 
 
In this case a screening approach would be helpful. For example, a column based approach 
with poly(U) sepharose column to capture RNAs with poly(A) tails longer than 50 bases 
(Udagawa et al., 2013). With recent advances in RNAseq and the many modifications 
developed for specific purposes, this can be applied to perform genome-wide measurements 
of poly(A) tail lengths. One such method is TAIL-seq,  which via ligating an adapter at the 
end of the poly(A) tail, generates libraries only from the 3’UTR and poly(A) tail, allowing 
much higher resolution in this region than would be provided by standard RNAseq protocols 
(Chang et al., 2014). Surprisingly, the study revealed that poly(A) tail length does not 
correlate with translation efficiency in terms of ribosome density and translation rate reported 
in other studies, but a mild correlation is found with mRNA half-lives, where mRNAs with a 
longer poly(A) tail generally have longer half-lives (Aviner et al., 2013; Chang et al., 2014; 
Schwanhäusser et al., 2011). This agrees with the notion that poly(A) tail length and 
deadenylation drives mRNAs into decay pathways.   
 
4.4.4 Retrograde transport of locally translated proteins 
 
One important question arising from the RNAseq data is: What are the mRNAs of 
transcription factors doing in the axon? One hypothesis is retrograde signalling, where factors 
that elicit a cell body response for injury is translated in the axon tip and retrogradely 
transported back to the cell nucleus. For example, retrograde transport of Importin β1, part of 
a protein complex that binds nuclear localisation signals (NLS) and is transported in a 
retrograde manner towards the cell body, is translated locally in axons (Hanz et al., 2003). 
Saturating retrograde transport with NLS peptides abolishes the regenerative effect of a 
conditioning lesion in sciatic nerve and axon specific depletion of Importin β1 mRNA 
reduces the transcriptional response to nerve injury in DRGs and delays functional recovery 
(Hanz et al., 2003; Perry et al., 2012). Knockout of Cpeb1 in injured processes down-
regulates genes related to nuclear import (Fig. 26E), suggesting that the retrograde transport 
in injury response is Cpeb1-dependent. Similar to Cpeb1 knockout in our data (Fig. 26C), 
axonal depletion of Importin β1 has little effect in uninjured neurons, in line with its role as a 
mediator of injury response. Importin β1 mRNA is localised to axons via its 3’UTR (Perry et 
al., 2012), affirming the role of 3’UTR in harbouring targeting elements for mRNAs and 
making it a potential Cpeb1 target. However, despite CPEs being present on the 3’UTR of 
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Importin β1, Cpeb1 knockout did not alter the polyadenylation status of the mRNA (Fig. 37). 
It would be of interest to perform mRNA stability assay and deletion of the CPE motif on 
Importin β1 mRNA, to ascertain if Cpeb1 has any effect on its degradation and transport. 
Retrograde transport were also discovered for signalling molecules upstream of the JNK 
pathway such as Mekk1, Map2k7, Map2k4 and Mlk3, following sciatic nerve axotomy, with 
increasing nuclear phosphorylation of c-Jun (Lindwall and Kanje, 2005). While this agrees 
with the model of the injured axons signalling the cell body to initiate a response, it casts 
doubt over why is there up-regulation of c-Jun mRNA in injured processes (Fig. 30). 
However, another study observed c-Jun proteins in dendrites, lending support to the notion of 
localised translation of c-Jun. Additionally, Cpeb1 was found to bind the 3’UTR of c-Jun 
mRNA in hippocampal neurons, and knockout of Cpeb1 reduces c-Jun protein levels and 
growth hormone (GH) mRNA, a target gene of c-Jun (Zearfoss et al., 2008). Therefore it is 
hypothesised that Cpeb1 induces axonal localisation or translation of c-Jun, which is 
subsequently transported back into the nucleus where it induces transcription of GH. The lack 
of change in c-Jun mRNA stability after Cpeb1 knockout confirms that it does not work via 
protecting the mRNA from degradation (Fig. 31 and 33). Similar behaviour of Junb, c-Fos 
and Fosb mRNAs suggests they are regulated in the same way.  More experiments are needed 
to prove if this is indeed the case. If true, then there would be a redundancy of having two 
mechanisms to get c-Jun into the nucleus, perhaps as a way to amplify the injury response. 
 
4.5 Conclusion 
 
In summary, starting from TSAA using SCI as a model, we discovered that uncoupling of 
transcription and translation is a widespread phenomenon in the injury response. Translation 
of mRNAs related to CNS development appears to be prioritised in the acute phase after 
injury, and limitations in their mRNA abundance likely lead to the eventual failure in 
regeneration. Many uncoupled genes were found to be regulators of axonal growth, 
demonstrating that uncoupling behaviour could be used for screening for regulators of 
regeneration. In addition, Cpeb1 was identified to be a regulator of mRNA abundance after 
neuronal injury, as well as being a positive regulator of neuronal regeneration in both mice 
and Drosophila, with highly conserved functions across the two species. Knockout of Cpeb1 
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greatly attenuated the transcriptome response of injured processes in cortical neurons. It was 
also discovered that there is substantial APA and increase in RNA stability upon injury in 
cortical neurons. The direct targets and exact mechanism through which Cpeb1 exerts its 
function remains elusive, however, as the experiments in this study could not identify targets 
for Cpeb1-mediated mRNA stability or polyadenylation.  
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